Component
NADPH
Reducing-equivalent donor for thioredoxin reductases.
115 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human FMO1 converted hypotaurine to taurine with either NADPH or NADH as the reducing cofactor in the reported assays.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human FMO1 biochemistry.
- limitations
- NAD(P)H availability, FMO1 abundance and substrate availability are separate variables; no niacin repletion effect was tested.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- Niacin-derived electron carriers support this synthetic reaction.
- primary_references
- Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32156684/ · DOI 10.1124/dmd.119.089995
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 81–87
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human FMO1 biochemistry. · source_derived_draft · unverified_draft
## taurine-fmo1-reducing-cofactors Niacin-derived electron carriers support this synthetic reaction. Human FMO1 converted hypotaurine to taurine with either NADPH or NADH as the reducing cofactor in the reported assays. Model: Recombinant human FMO1 biochemistry. Limitations: NAD(P)H availability, FMO1 abundance and substrate availability are separate variables; no niacin repletion effect was tested. Evidence access: Primary abstract Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32156684/ · DOI 10.1124/dmd.119.089995
Complete structured claim and evidenceNADPH sensitized vanadate-resistant cells and increased phosphotyrosine signals and Ras expression in the reported experiment.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-line NADPH intervention.
- limitations
- Changes support redox-dependent signaling but do not directly demonstrate each proposed vanadium intermediate.
- nutrient_topic
- Vanadium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Vanadium
- plain_language
- More reducing power did not necessarily protect against this metal exposure.
- primary_references
- Mechanisms of vanadate-induced cellular toxicity: role of cellular glutathione and NADPH. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12234491/ · DOI 10.1016/s0003-9861(02)00408-3
Vanadium: speciation, phosphate-sensitive enzymes and cross-nutrient mechanisms (2026-09-19) · lines 150–156
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-line NADPH intervention. · source_derived_draft · unverified_draft
## vanadium-nadph-sensitization More reducing power did not necessarily protect against this metal exposure. NADPH sensitized vanadate-resistant cells and increased phosphotyrosine signals and Ras expression in the reported experiment. Model: Cell-line NADPH intervention. Limitations: Changes support redox-dependent signaling but do not directly demonstrate each proposed vanadium intermediate. Evidence access: Primary abstract Mechanisms of vanadate-induced cellular toxicity: role of cellular glutathione and NADPH. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12234491/ · DOI 10.1016/s0003-9861(02)00408-3
Complete structured claim and evidenceFSP1 used NAD(P)H to regenerate the reduced CoQ pool that traps lipid peroxyl radicals.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/coq10-research/31634899.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1e96f6d5aed6def29533d907cd9ae90bc287d3f7beb6b9447aec3308d57a0dfe", "start_char": 0, "end_char": 1818, "text_sha256": "1e96f6d5aed6def29533d907cd9ae90bc287d3f7beb6b9447aec3308d57a0dfe"}
- experimental_model
- Expression cloning and cell-death experiments
- exposure
- GPX4 deletion or inhibitors and FSP1 manipulation
- limitations
- Cancer-cell defense mechanism; preventing ferroptosis is not always a desirable disease outcome and oral CoQ benefit is not tested.
- nutrient_topic
- Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. · Coenzyme Q10 / CoQ10 redox system
- organism
- Human cancer-cell models
- plain_language
- The antioxidant form must be regenerated using reducing power.
- primary_references
- [coq10-p31634899] FSP1 is a glutathione-independent ferroptosis suppressor. (2019). https://pubmed.ncbi.nlm.nih.gov/31634899/ DOI: 10.1038/s41586-019-1707-0
- tissue_or_cell_type
- FSP1-CoQ antioxidant pathway
Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17) · lines 801–812
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Expression cloning and cell-death experiments · source_derived_draft · unverified_draft
### coq10-fsp1-nadph FSP1 used NAD(P)H to regenerate the reduced CoQ pool that traps lipid peroxyl radicals. Condition category: normal nutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The antioxidant form must be regenerated using reducing power. organism: Human cancer-cell models tissue_or_cell_type: FSP1-CoQ antioxidant pathway experimental_model: Expression cloning and cell-death experiments limitations: Cancer-cell defense mechanism; preventing ferroptosis is not always a desirable disease outcome and oral CoQ benefit is not tested. exposure: GPX4 deletion or inhibitors and FSP1 manipulation evidence_span: {"source_cache": "artifacts/coq10-research/31634899.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1e96f6d5aed6def29533d907cd9ae90bc287d3f7beb6b9447aec3308d57a0dfe", "start_char": 0, "end_char": 1818, "text_sha256": "1e96f6d5aed6def29533d907cd9ae90bc287d3f7beb6b9447aec3308d57a0dfe"} [coq10-p31634899] FSP1 is a glutathione-independent ferroptosis suppressor. (2019). https://pubmed.ncbi.nlm.nih.gov/31634899/ DOI: 10.1038/s41586-019-1707-0
Complete structured claim and evidenceCinnamaldehyde-dependent time-dependent inhibition of CYP2A6 required NADPH in the reconstituted assay.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/ceylon-research/26851241.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2", "start_char": 0, "end_char": 1591, "text_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2"}
- experimental_model
- Recombinant human CYP assays and mechanistic static modeling
- exposure
- Cinnamaldehyde, NADPH and glutathione; modeled inhibitor concentrations 0.1 and 1 micromolar
- limitations
- Enzyme inhibition and model predictions are not measured clinical drug interactions. NADPH omission is not dietary niacin deficiency.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Human enzyme preparations; computational model
- plain_language
- The enzyme had to receive reducing power for this inactivation process to develop.
- primary_references
- [ceylon-p26851241] Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. (2016). https://pubmed.ncbi.nlm.nih.gov/26851241/ DOI: 10.1124/dmd.115.067942
- tissue_or_cell_type
- CYP2A6 reaction system
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 753–764
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human CYP assays and mechanistic static modeling · source_derived_draft · unverified_draft
### ceylon-nadph-dependence Cinnamaldehyde-dependent time-dependent inhibition of CYP2A6 required NADPH in the reconstituted assay. Condition category: machinery_impairment nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: The enzyme had to receive reducing power for this inactivation process to develop. organism: Human enzyme preparations; computational model tissue_or_cell_type: CYP2A6 reaction system experimental_model: Recombinant human CYP assays and mechanistic static modeling limitations: Enzyme inhibition and model predictions are not measured clinical drug interactions. NADPH omission is not dietary niacin deficiency. exposure: Cinnamaldehyde, NADPH and glutathione; modeled inhibitor concentrations 0.1 and 1 micromolar evidence_span: {"source_cache": "artifacts/ceylon-research/26851241.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2", "start_char": 0, "end_char": 1591, "text_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2"} [ceylon-p26851241] Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. (2016). https://pubmed.ncbi.nlm.nih.gov/26851241/ DOI: 10.1124/dmd.115.067942
Complete structured claim and evidenceThe purified two-step reduction depended on NADPH.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"}
- experimental_model
- Purification and characterization of a human-fecal bacterial enzyme
- exposure
- Curcumin and reduced intermediates; NADPH-dependent reactions
- limitations
- Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Escherichia coli isolate
- plain_language
- This bacterial reaction draws on NADPH reducing power.
- primary_references
- [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
- tissue_or_cell_type
- Purified CurA
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 229–240
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purification and characterization of a human-fecal bacterial enzyme · source_derived_draft · unverified_draft
### curcumin-cura-nadph The purified two-step reduction depended on NADPH. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: This bacterial reaction draws on NADPH reducing power. organism: Escherichia coli isolate tissue_or_cell_type: Purified CurA experimental_model: Purification and characterization of a human-fecal bacterial enzyme limitations: Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion. exposure: Curcumin and reduced intermediates; NADPH-dependent reactions evidence_span: {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"} [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
Complete structured claim and evidenceHuman GSR substrate structures place NADPH for hydride transfer to bound FAD, the first redox step in glutathione recycling.
Experimental context and source evidence
- cross_nutrient
- Nicotinamide-containing NADPH and B2-derived FAD perform distinct functions.
- evidence_location
- Results: NADPH binding; Fig 1 consensus cycle; GSH/GSSG complexes
- experimental_model
- Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls.
- exposure
- Purified-enzyme assay
- limitations
- Structural support for the established catalytic cycle; radiation reduction must be distinguished from natural catalysis.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- NADPH supplies electrons to the B2-derived cofactor.
- primary_references
- [berkholz2008] Catalytic cycle of human glutathione reductase near 1 A resolution. (2008). https://pubmed.ncbi.nlm.nih.gov/18638483/ DOI: 10.1016/j.jmb.2008.06.083
- tissue_or_cell_type
- Purified human erythrocyte-type GSR crystals
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1304–1316
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls. · source_derived_draft · unverified_draft
### b2-gsr-nadph-to-fad Human GSR substrate structures place NADPH for hydride transfer to bound FAD, the first redox step in glutathione recycling. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: NADPH supplies electrons to the B2-derived cofactor. organism: Homo sapiens tissue_or_cell_type: Purified human erythrocyte-type GSR crystals experimental_model: Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls. limitations: Structural support for the established catalytic cycle; radiation reduction must be distinguished from natural catalysis. exposure: Purified-enzyme assay cross_nutrient: Nicotinamide-containing NADPH and B2-derived FAD perform distinct functions. evidence_location: Results: NADPH binding; Fig 1 consensus cycle; GSH/GSSG complexes [berkholz2008] Catalytic cycle of human glutathione reductase near 1 A resolution. (2008). https://pubmed.ncbi.nlm.nih.gov/18638483/ DOI: 10.1016/j.jmb.2008.06.083
Complete structured claim and evidenceNADPH reduction of purified MTRR generated an air-stable flavin semiquinone detected spectroscopically.
Experimental context and source evidence
- cross_nutrient
- Nicotinamide-containing NADPH supplies electrons to B2-derived flavins.
- evidence_location
- Abstract
- experimental_model
- Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution.
- exposure
- Purified-enzyme assay
- limitations
- Biochemical evidence does not establish a dietary threshold or supplementation benefit.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- NADPH provides electrons to the flavin-containing reductase.
- primary_references
- [olteanu2001] Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. (2001). https://pubmed.ncbi.nlm.nih.gov/11466310/ DOI: 10.1074/jbc.m103707200
- tissue_or_cell_type
- Purified recombinant enzyme; no intact tissue
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1108–1120
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution. · source_derived_draft · unverified_draft
### b2-mtrr-nadph-reduction NADPH reduction of purified MTRR generated an air-stable flavin semiquinone detected spectroscopically. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: NADPH provides electrons to the flavin-containing reductase. organism: Homo sapiens tissue_or_cell_type: Purified recombinant enzyme; no intact tissue experimental_model: Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution. limitations: Biochemical evidence does not establish a dietary threshold or supplementation benefit. exposure: Purified-enzyme assay cross_nutrient: Nicotinamide-containing NADPH supplies electrons to B2-derived flavins. evidence_location: Abstract [olteanu2001] Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. (2001). https://pubmed.ncbi.nlm.nih.gov/11466310/ DOI: 10.1074/jbc.m103707200
Complete structured claim and evidenceNADPH also functioned as an electron donor for the purified E. coli azoreductase preparations.
Experimental context and source evidence
- dose
- Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract
- duration
- Assay interval unavailable in primary abstract
- evidence_access
- Primary PubMed abstract; unrecovered method details explicitly retained.
- evidence_scope
- literature_reviewed; source-specific experimental curation
- experimental_model
- Purified Escherichia coli K12 azoreductases I and II
- limitations
- Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved.
- nutrient_topic
- Tartrazine food-colorant chapter; nutrient, drug and peptide interactions retain their models and limits. · Tartrazine
- organism
- Purified Escherichia coli K12 azoreductases I and II
- plain_language
- NADPH also functioned as an electron donor for the purified E. coli azoreductase preparations.
- primary_references
- Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/
- route
- In vitro enzyme/substrate incubation
- tissue
- Cell-free azo-reduction assays
Tartrazine: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 50–59
Original AI-assisted curation of eighteen primary studies. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Purified Escherichia coli K12 azoreductases I and II · source_derived_draft · unverified_draft
## tartrazine-nadph-donor NADPH also functioned as an electron donor for the purified E. coli azoreductase preparations. Model/species: Purified Escherichia coli K12 azoreductases I and II Tissue: Cell-free azo-reduction assays Exposure: Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract Route: In vitro enzyme/substrate incubation Duration: Assay interval unavailable in primary abstract Limits: Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved. Primary reference: Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/ Access: Primary PubMed abstract; unrecovered method details explicitly retained.
Complete structured claim and evidenceP5CS requires NADPH for its reductive step in glutamate-to-P5C synthesis.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"}
- experimental_model
- Patient genetics and recombinant variant expression
- exposure
- ALDH18A1 R84Q compared with wild-type isoforms
- limitations
- Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, two siblings and mammalian expression systems
- plain_language
- A niacin-derived electron donor participates upstream of citrulline.
- primary_references
- [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
- tissue_or_cell_type
- Mitochondrial P5CS and circulating amino acids
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 307–318
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient genetics and recombinant variant expression · source_derived_draft · unverified_draft
### citrulline-p5cs-nadph P5CS requires NADPH for its reductive step in glutamate-to-P5C synthesis. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A niacin-derived electron donor participates upstream of citrulline. organism: Human, two siblings and mammalian expression systems tissue_or_cell_type: Mitochondrial P5CS and circulating amino acids experimental_model: Patient genetics and recombinant variant expression limitations: Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype. exposure: ALDH18A1 R84Q compared with wild-type isoforms evidence_span: {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"} [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
Complete structured claim and evidenceA thioredoxin-reductase/NADPH system reduced GLRX2 disulfide and GSH-GLRX2 intermediates.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/14676218.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a7399b7d035bd3815c30362449b7986dea08873c824e05506d7db627a71daa84", "start_char": 0, "end_char": 1398, "text_sha256": "a7399b7d035bd3815c30362449b7986dea08873c824e05506d7db627a71daa84"}
- experimental_model
- Purified human glutaredoxin kinetics and mutants
- exposure
- GSH or NADPH/thioredoxin-reductase donor systems
- limitations
- Thioredoxin-reductase isoform is not assigned from the indexed abstract; this is not a new selenium-dose response.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human GLRX1/GLRX2
- plain_language
- Glutaredoxin recovery also had an alternative donor route in the assay.
- primary_references
- [glutathione-p14676218] Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. (2004). https://pubmed.ncbi.nlm.nih.gov/14676218/ DOI: 10.1074/jbc.m312719200
- tissue_or_cell_type
- Glutathionylated substrates
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 827–838
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human glutaredoxin kinetics and mutants · source_derived_draft · unverified_draft
### glutathione-glrx2-alternative-donor A thioredoxin-reductase/NADPH system reduced GLRX2 disulfide and GSH-GLRX2 intermediates. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutaredoxin recovery also had an alternative donor route in the assay. organism: Human GLRX1/GLRX2 tissue_or_cell_type: Glutathionylated substrates experimental_model: Purified human glutaredoxin kinetics and mutants limitations: Thioredoxin-reductase isoform is not assigned from the indexed abstract; this is not a new selenium-dose response. exposure: GSH or NADPH/thioredoxin-reductase donor systems evidence_span: {"source_cache": "artifacts/glutathione-research/14676218.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a7399b7d035bd3815c30362449b7986dea08873c824e05506d7db627a71daa84", "start_char": 0, "end_char": 1398, "text_sha256": "a7399b7d035bd3815c30362449b7986dea08873c824e05506d7db627a71daa84"} [glutathione-p14676218] Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. (2004). https://pubmed.ncbi.nlm.nih.gov/14676218/ DOI: 10.1074/jbc.m312719200
Complete structured claim and evidencePurified human RDH12 used NADPH for retinal reduction and had much lower apparent cofactor Km for NADP(H) than NAD(H).
Experimental context and source evidence
- experimental_model
- Purified-enzyme cofactor/substrate kinetics
- limitations
- Biochemical cofactor preference does not demonstrate a dietary niacin-deficiency visual phenotype.
- nutrient_topic
- Vitamin A research collection; topical membership is not evidence of a direct dietary effect. · Vitamin A
- organism
- Homo sapiens protein
- plain_language
- The reductase uses NADPH reducing power to convert retinal into retinol.
- primary_references
- [belyaeva-2005] Biochemical properties of purified human retinol dehydrogenase 12 (RDH12): catalytic efficiency toward retinoids and C9 aldehydes and effects of cellular retinol-binding protein type I (CRBPI) and cellular retinaldehyde-binding protein (CRALBP) on the oxidation and reduction of retinoids (2005). https://pubmed.ncbi.nlm.nih.gov/15865448/ DOI: 10.1021/bi050226k
- tissue_or_cell_type
- Recombinant enzyme preparation
Vitamin A: forms, mechanisms, deficiency and excess (2026-09-17) · lines 778–787
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified-enzyme cofactor/substrate kinetics · source_derived_draft · unverified_draft
### a-vision-rdh12-nadph Purified human RDH12 used NADPH for retinal reduction and had much lower apparent cofactor Km for NADP(H) than NAD(H). Condition category: normal nutrient_topic: Vitamin A research collection; topical membership is not evidence of a direct dietary effect. plain_language: The reductase uses NADPH reducing power to convert retinal into retinol. organism: Homo sapiens protein tissue_or_cell_type: Recombinant enzyme preparation experimental_model: Purified-enzyme cofactor/substrate kinetics limitations: Biochemical cofactor preference does not demonstrate a dietary niacin-deficiency visual phenotype. [belyaeva-2005] Biochemical properties of purified human retinol dehydrogenase 12 (RDH12): catalytic efficiency toward retinoids and C9 aldehydes and effects of cellular retinol-binding protein type I (CRBPI) and cellular retinaldehyde-binding protein (CRALBP) on the oxidation and reduction of retinoids (2005). https://pubmed.ncbi.nlm.nih.gov/15865448/ DOI: 10.1021/bi050226k
Complete structured claim and evidenceRat liver microsomes formed initial alpha- and gamma-tocopherol side-chain oxidation products with NADPH but not without it.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Cofactor omission/addition; Figure 6
- exposure
- 0.5 mM NADPH; reaction followed for 80 minutes.
- limitations
- Direct NADPH dependence; no dietary niacin or riboflavin shortage, universal supplement combination or magnesium requirement was tested.
- nutrient_topic
- Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
- organism
- Rattus norvegicus
- plain_language
- The initial microsomal oxidation required a reducing cofactor.
- primary_references
- [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
- tissue_or_cell_type
- Liver microsomes
Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 441–452
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cofactor omission/addition; Figure 6 · source_derived_draft · unverified_draft
### ve-transport-nadph-microsomal-oxidation Rat liver microsomes formed initial alpha- and gamma-tocopherol side-chain oxidation products with NADPH but not without it. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The initial microsomal oxidation required a reducing cofactor. organism: Rattus norvegicus tissue_or_cell_type: Liver microsomes experimental_model: Cofactor omission/addition; Figure 6 limitations: Direct NADPH dependence; no dietary niacin or riboflavin shortage, universal supplement combination or magnesium requirement was tested. exposure: 0.5 mM NADPH; reaction followed for 80 minutes. cross_nutrient: true [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
Complete structured claim and evidenceNADPH protected against inhibition, and ketoacyl-reductase experiments supported competition near the NADPH-binding function.
Experimental context and source evidence
- experimental_model
- Purified chicken FAS kinetics.
- limitations
- This does not show that niacin supplementation cancels EGCG or improves a clinical outcome.
- nutrient_topic
- EGCG collection; comparator and shared-pathway records retain their actual intervention. · Epigallocatechin-3-gallate (EGCG)
- plain_language
- The enzyme’s reducing cofactor altered EGCG inhibition.
- primary_references
- Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11700039/ · DOI 10.1006/bbrc.2001.5923
EGCG: receptor signaling, metabolism, nutrient interactions and discovery questions (2026-09-18) · lines 204–210
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Purified chicken FAS kinetics. · source_derived_draft · unverified_draft
## egcg-fasn-nadph The enzyme’s reducing cofactor altered EGCG inhibition. NADPH protected against inhibition, and ketoacyl-reductase experiments supported competition near the NADPH-binding function. Model: Purified chicken FAS kinetics. Limitations: This does not show that niacin supplementation cancels EGCG or improves a clinical outcome. Evidence access: primary abstract. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11700039/ · DOI 10.1006/bbrc.2001.5923
Complete structured claim and evidence
What acts on it
The same monacolin K inhibition was noncompetitive with respect to NADPH.
Experimental context and source evidence
- evidence_access
- Primary PDF, p335 visually inspected
- experimental_model
- Rat liver reductase kinetics in the 1980 study.
- limitations
- Not evidence of NADPH depletion, niacin deficiency or reversal by niacin supplementation.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The reducing cofactor and the competing substrate have different roles.
- primary_references
- [7380744] Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. · 1980 · https://pubmed.ncbi.nlm.nih.gov/7380744/ · DOI 10.7164/antibiotics.33.334
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 60–66
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat liver reductase kinetics in the 1980 study. · source_derived_draft · unverified_draft
## red-yeast-rice-nadph-noncompetition The reducing cofactor and the competing substrate have different roles. The same monacolin K inhibition was noncompetitive with respect to NADPH. Model: Rat liver reductase kinetics in the 1980 study. Limitations: Not evidence of NADPH depletion, niacin deficiency or reversal by niacin supplementation. Evidence access: Primary PDF, p335 visually inspected [7380744] Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. · 1980 · https://pubmed.ncbi.nlm.nih.gov/7380744/ · DOI 10.7164/antibiotics.33.334
Complete structured claim and evidenceNADPH was also oxidized under the LPO/H2O2/iodide conditions.
Experimental context and source evidence
- experimental_model
- Cell-free LPO/H2O2 reactions with nicotinamide nucleotides.
- exposure_category
- Study-specific exposure, including pharmacological and in-vitro conditions; normal is the schema fallback outside the three availability categories.
- limitations
- Chemical oxidation is not evidence that supplementation drains niacin in vivo; the authors expected thiocyanate oxidation to predominate in milk/saliva.
- nutrient_topic
- Potassium iodide research collection; shared-anion and comparator studies are not all KI interventions. · Potassium iodide
- plain_language
- The chemistry also reaches the NADPH reducing pool.
- primary_references
- The oxidation of reduced nicotinamide nucleotides by hydrogen peroside in the presence of lactoperoxidase and thiocyanate, iodide or bromide. · 1970 · https://pubmed.ncbi.nlm.nih.gov/4317722/ · DOI 10.1042/bj1170791
Potassium iodide: thyroid and non-thyroid mechanisms, interactions and discovery questions (2026-09-18) · lines 264–270
AI-assisted research curation; primary-study references, chemical references and label statements individually identified. Not publisher full text. · supports · Cell-free LPO/H2O2 reactions with nicotinamide nucleotides. · source_derived_draft · unverified_draft
## ki-nadph The chemistry also reaches the NADPH reducing pool. NADPH was also oxidized under the LPO/H2O2/iodide conditions. Model: Cell-free LPO/H2O2 reactions with nicotinamide nucleotides. Limitations: Chemical oxidation is not evidence that supplementation drains niacin in vivo; the authors expected thiocyanate oxidation to predominate in milk/saliva. Evidence location: Primary abstract The oxidation of reduced nicotinamide nucleotides by hydrogen peroside in the presence of lactoperoxidase and thiocyanate, iodide or bromide. · 1970 · https://pubmed.ncbi.nlm.nih.gov/4317722/ · DOI 10.1042/bj1170791
Complete structured claim and evidenceStructural analysis of mammalian NNT supported coupling of NADH-to-NADP+ hydride transfer to proton translocation across the mitochondrial membrane.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nnt-structure-2019.abstract.txt", "locator": "Indexed abstract, reaction and structural mechanism", "start_char": 199, "end_char": 1759, "file_sha256": "edb35c2cdf2f57d604cb86da48665e5742d398f43c50f3e1622d161564c78a83", "text_sha256": "aa5063e57c35097c2fa2557ed9a7d61c3a411d90d0ded9b947525012520a5712"}
- experimental_model
- Cryo-EM of intact ovine NNT in different nucleotide states
- exposure
- Nucleotide-bound conformational states
- limitations
- Structural mechanism supported in ovine protein; forward flux is context dependent and not equivalent to adding phosphate to NAD. No human intake inference.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Ovis aries
- plain_language
- NNT links the NADH and NADPH redox systems through membrane-coupled chemistry.
- primary_references
- [nnt-structure-2019] Structure and mechanism of mitochondrial proton-translocating transhydrogenase. (2019). https://pubmed.ncbi.nlm.nih.gov/31462775/ DOI: 10.1038/s41586-019-1519-2
- tissue_or_cell_type
- Purified mitochondrial protein
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 1003–1014
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cryo-EM of intact ovine NNT in different nucleotide states · source_derived_draft · unverified_draft
### b3-redox-nnt-coupling Structural analysis of mammalian NNT supported coupling of NADH-to-NADP+ hydride transfer to proton translocation across the mitochondrial membrane. Condition category: normal nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: NNT links the NADH and NADPH redox systems through membrane-coupled chemistry. organism: Ovis aries tissue_or_cell_type: Purified mitochondrial protein experimental_model: Cryo-EM of intact ovine NNT in different nucleotide states limitations: Structural mechanism supported in ovine protein; forward flux is context dependent and not equivalent to adding phosphate to NAD. No human intake inference. exposure: Nucleotide-bound conformational states evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nnt-structure-2019.abstract.txt", "locator": "Indexed abstract, reaction and structural mechanism", "start_char": 199, "end_char": 1759, "file_sha256": "edb35c2cdf2f57d604cb86da48665e5742d398f43c50f3e1622d161564c78a83", "text_sha256": "aa5063e57c35097c2fa2557ed9a7d61c3a411d90d0ded9b947525012520a5712"} [nnt-structure-2019] Structure and mechanism of mitochondrial proton-translocating transhydrogenase. (2019). https://pubmed.ncbi.nlm.nih.gov/31462775/ DOI: 10.1038/s41586-019-1519-2
Complete structured claim and evidenceIn the cardiac pathological-workload study, reverse-mode Nnt consumed NADPH while supporting NADH and ATP production.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nnt-reverse-2015.abstract.txt", "locator": "Indexed abstract, pathological workload results", "start_char": 373, "end_char": 1028, "file_sha256": "88e6510d357946cd087e5af7ca3c9fdfd2ac22f2fb1851dd1164f176c5e39ce4", "text_sha256": "a8e2d67ccb1f5f041786aecfb33760602a804017dccfe41c54b34213ea0c6223"}
- experimental_model
- Mouse cardiac pressure-overload / pathological-demand experiments
- exposure
- Pathological cardiac metabolic demand
- limitations
- Context-dependent reversal, not genetic kinase failure or dietary niacin deficiency. Abstract-only extraction; do not generalize to all hearts or propose NNT inhibition clinically.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Mus musculus
- plain_language
- Under this high-workload condition Nnt used up NADPH instead of supplying it.
- primary_references
- [nnt-reverse-2015] Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure. (2015). https://pubmed.ncbi.nlm.nih.gov/26256392/ DOI: 10.1016/j.cmet.2015.07.008
- tissue_or_cell_type
- Heart
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 1016–1027
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse cardiac pressure-overload / pathological-demand experiments · source_derived_draft · unverified_draft
### b3-redox-nnt-reversal In the cardiac pathological-workload study, reverse-mode Nnt consumed NADPH while supporting NADH and ATP production. Condition category: machinery_impairment nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Under this high-workload condition Nnt used up NADPH instead of supplying it. organism: Mus musculus tissue_or_cell_type: Heart experimental_model: Mouse cardiac pressure-overload / pathological-demand experiments limitations: Context-dependent reversal, not genetic kinase failure or dietary niacin deficiency. Abstract-only extraction; do not generalize to all hearts or propose NNT inhibition clinically. exposure: Pathological cardiac metabolic demand evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nnt-reverse-2015.abstract.txt", "locator": "Indexed abstract, pathological workload results", "start_char": 373, "end_char": 1028, "file_sha256": "88e6510d357946cd087e5af7ca3c9fdfd2ac22f2fb1851dd1164f176c5e39ce4", "text_sha256": "a8e2d67ccb1f5f041786aecfb33760602a804017dccfe41c54b34213ea0c6223"} [nnt-reverse-2015] Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure. (2015). https://pubmed.ncbi.nlm.nih.gov/26256392/ DOI: 10.1016/j.cmet.2015.07.008
Complete structured claim and evidenceHuman G6PD uses glucose-6-phosphate and catalytic NADP+ to generate NADPH.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35858355.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "02c2d0e880b17ab304fab0854064813ffec5fa9e647b978a083aa88fbf8a38f0", "start_char": 0, "end_char": 1328, "text_sha256": "02c2d0e880b17ab304fab0854064813ffec5fa9e647b978a083aa88fbf8a38f0"}
- experimental_model
- Cryo-EM and structural comparison
- exposure
- Ligand-free and NADP/G6P-bound states
- limitations
- Structural NADP and catalytic NADP are different sites; enzyme activity is not a niacin-treatment trial.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- The reducing power used in glutathione recycling has to be replenished.
- primary_references
- [glutathione-p35858355] Allosteric role of a structural NADP+ molecule in glucose-6-phosphate dehydrogenase activity. (2022). https://pubmed.ncbi.nlm.nih.gov/35858355/ DOI: 10.1073/pnas.2119695119
- tissue_or_cell_type
- Purified wild-type G6PD and D200N
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 762–773
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cryo-EM and structural comparison · source_derived_draft · unverified_draft
### glutathione-g6pd-nadph Human G6PD uses glucose-6-phosphate and catalytic NADP+ to generate NADPH. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The reducing power used in glutathione recycling has to be replenished. organism: Human tissue_or_cell_type: Purified wild-type G6PD and D200N experimental_model: Cryo-EM and structural comparison limitations: Structural NADP and catalytic NADP are different sites; enzyme activity is not a niacin-treatment trial. exposure: Ligand-free and NADP/G6P-bound states evidence_span: {"source_cache": "artifacts/glutathione-research/35858355.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "02c2d0e880b17ab304fab0854064813ffec5fa9e647b978a083aa88fbf8a38f0", "start_char": 0, "end_char": 1328, "text_sha256": "02c2d0e880b17ab304fab0854064813ffec5fa9e647b978a083aa88fbf8a38f0"} [glutathione-p35858355] Allosteric role of a structural NADP+ molecule in glucose-6-phosphate dehydrogenase activity. (2022). https://pubmed.ncbi.nlm.nih.gov/35858355/ DOI: 10.1073/pnas.2119695119
Complete structured claim and evidencePurified full-length human MTHFR had apparent Km values of 35.5 micromolar for NADPH and 3760 micromolar for NADH.
Experimental context and source evidence
- cross_nutrient
- Folate reduction uses nicotinamide reducing equivalents.
- experimental_model
- Recombinant human MTHFR; kinetics and structures.
- limitations
- Affinity does not quantify cellular flux.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- MTHFR strongly preferred NADPH in this assay.
- primary_references
- [froese-2018] Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition (2018). https://pubmed.ncbi.nlm.nih.gov/29891918/ DOI: 10.1038/s41467-018-04735-2
- tissue_or_cell_type
- Purified protein
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 435–445
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MTHFR; kinetics and structures. · source_derived_draft · unverified_draft
### folate-methyl-nadph-preference Purified full-length human MTHFR had apparent Km values of 35.5 micromolar for NADPH and 3760 micromolar for NADH. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: MTHFR strongly preferred NADPH in this assay. organism: Homo sapiens tissue_or_cell_type: Purified protein experimental_model: Recombinant human MTHFR; kinetics and structures. limitations: Affinity does not quantify cellular flux. cross_nutrient: Folate reduction uses nicotinamide reducing equivalents. [froese-2018] Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition (2018). https://pubmed.ncbi.nlm.nih.gov/29891918/ DOI: 10.1038/s41467-018-04735-2
Complete structured claim and evidence
Where it participates (unsigned role)
Liver-specific Pcx deletion depleted hepatic NADPH and worsened oxidative stress.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/biotin-research/31006591.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0dcedbfac623863bd4ae86ed1bb97cef0ef56bd417bd0d49507ef47d16af7b4e", "start_char": 0, "end_char": 1141, "text_sha256": "0dcedbfac623863bd4ae86ed1bb97cef0ef56bd417bd0d49507ef47d16af7b4e"}
- experimental_model
- Liver-specific Pcx-knockout mice
- exposure
- Genetic deletion of hepatic pyruvate carboxylase
- limitations
- Genetic enzyme deletion is not a dietary biotin experiment. Cross-nutrient implications identify pathway dependence rather than a proven supplement response.
- nutrient_topic
- Biotin research collection; topical membership is not evidence of a direct dietary effect. · Biotin
- organism
- Mus musculus
- plain_language
- Failure of this carbon-supply step can affect the niacin-derived reducing-power pool.
- primary_references
- [b7-p31006591] Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver. (2019). https://pubmed.ncbi.nlm.nih.gov/31006591/ DOI: 10.1016/j.cmet.2019.03.014
- tissue_or_cell_type
- Liver and systemic metabolism
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Biotin: carboxylases, recycling, deficiency and nutrient interactions (2026-09-17) · lines 832–843
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Liver-specific Pcx-knockout mice · source_derived_draft · unverified_draft
### b7-pc-null-nadph Liver-specific Pcx deletion depleted hepatic NADPH and worsened oxidative stress. Condition category: machinery_impairment nutrient_topic: Biotin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Failure of this carbon-supply step can affect the niacin-derived reducing-power pool. organism: Mus musculus tissue_or_cell_type: Liver and systemic metabolism experimental_model: Liver-specific Pcx-knockout mice limitations: Genetic enzyme deletion is not a dietary biotin experiment. Cross-nutrient implications identify pathway dependence rather than a proven supplement response. exposure: Genetic deletion of hepatic pyruvate carboxylase evidence_span: {"source_cache": "artifacts/biotin-research/31006591.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0dcedbfac623863bd4ae86ed1bb97cef0ef56bd417bd0d49507ef47d16af7b4e", "start_char": 0, "end_char": 1141, "text_sha256": "0dcedbfac623863bd4ae86ed1bb97cef0ef56bd417bd0d49507ef47d16af7b4e"} [b7-p31006591] Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver. (2019). https://pubmed.ncbi.nlm.nih.gov/31006591/ DOI: 10.1016/j.cmet.2019.03.014
Complete structured claim and evidencePOR Y181D lacked bound FMN and poorly supported CYP1A2-catalyzed reactions despite retaining FAD binding and NADPH utilization.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/dim-research/19884324.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f702cc9af1528241d8572b8bcafc23dacb5ed3cacf6bb77403e8aa40d21a214", "start_char": 0, "end_char": 1738, "text_sha256": "3f702cc9af1528241d8572b8bcafc23dacb5ed3cacf6bb77403e8aa40d21a214"}
- experimental_model
- Recombinant protein and engineered bacterial coexpression
- exposure
- POR mutation and added FMN
- limitations
- In-vitro rescue of one mutant; not a dietary-riboflavin deficiency experiment or evidence that FMN reverses a DIM-drug interaction.
- nutrient_topic
- Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
- organism
- Human POR Y181D and human CYP1A2 in engineered systems
- plain_language
- Inducing an enzyme is not enough if its electron-supply machinery fails.
- primary_references
- [dim-p19884324] Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. (2010). https://pubmed.ncbi.nlm.nih.gov/19884324/ DOI: 10.1124/dmd.109.030445
- tissue_or_cell_type
- FMN-dependent electron transfer
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 272–283
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant protein and engineered bacterial coexpression · source_derived_draft · unverified_draft
### dim-por-fmn-loss POR Y181D lacked bound FMN and poorly supported CYP1A2-catalyzed reactions despite retaining FAD binding and NADPH utilization. Condition category: machinery_impairment nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Inducing an enzyme is not enough if its electron-supply machinery fails. organism: Human POR Y181D and human CYP1A2 in engineered systems tissue_or_cell_type: FMN-dependent electron transfer experimental_model: Recombinant protein and engineered bacterial coexpression limitations: In-vitro rescue of one mutant; not a dietary-riboflavin deficiency experiment or evidence that FMN reverses a DIM-drug interaction. exposure: POR mutation and added FMN evidence_span: {"source_cache": "artifacts/dim-research/19884324.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3f702cc9af1528241d8572b8bcafc23dacb5ed3cacf6bb77403e8aa40d21a214", "start_char": 0, "end_char": 1738, "text_sha256": "3f702cc9af1528241d8572b8bcafc23dacb5ed3cacf6bb77403e8aa40d21a214"} [dim-p19884324] Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. (2010). https://pubmed.ncbi.nlm.nih.gov/19884324/ DOI: 10.1124/dmd.109.030445
Complete structured claim and evidenceCYP1A2 was the predominant tested catalyst of tizanidine metabolism.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/dim-research/14998432.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f", "start_char": 0, "end_char": 1208, "text_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f"}
- experimental_model
- Human microsomes and recombinant CYP comparison
- exposure
- NADPH-dependent substrate consumption and selective inhibition
- limitations
- Enzyme phenotyping; not a trial of DIM with tizanidine.
- nutrient_topic
- Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. · 3,3'-Diindolylmethane / DIM
- organism
- Human CYP enzymes
- plain_language
- Tizanidine has a strong pathway connection, while the size and direction of a DIM interaction remain unmeasured.
- primary_references
- [dim-p14998432] Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro. (2004). https://pubmed.ncbi.nlm.nih.gov/14998432/ DOI: 10.1046/j.1365-2125.2003.02028.x
- tissue_or_cell_type
- Tizanidine metabolism
Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17) · lines 779–790
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human microsomes and recombinant CYP comparison · source_derived_draft · unverified_draft
### dim-tizanidine-1a2 CYP1A2 was the predominant tested catalyst of tizanidine metabolism. Condition category: normal nutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Tizanidine has a strong pathway connection, while the size and direction of a DIM interaction remain unmeasured. organism: Human CYP enzymes tissue_or_cell_type: Tizanidine metabolism experimental_model: Human microsomes and recombinant CYP comparison limitations: Enzyme phenotyping; not a trial of DIM with tizanidine. exposure: NADPH-dependent substrate consumption and selective inhibition evidence_span: {"source_cache": "artifacts/dim-research/14998432.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f", "start_char": 0, "end_char": 1208, "text_sha256": "fa9fa0887ce5587c5c1894fd10a4afa651eac8220683d06745675a72f3e1ba2f"} [dim-p14998432] Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro. (2004). https://pubmed.ncbi.nlm.nih.gov/14998432/ DOI: 10.1046/j.1365-2125.2003.02028.x
Complete structured claim and evidenceHuman CYP27B1 1alpha-hydroxylated 25-hydroxyvitamin D2 in phospholipid vesicles; low-substrate catalytic efficiency was similar to that measured for calcifediol.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved.
- experimental_model
- Partially purified human CYP27B1 membrane assay
- exposure
- 5-40 nM CYP27B1; 15 micromolar FDX1, 0.4 micromolar FDXR, 50 micromolar NADPH; 2 min at 37 C. Table 5/Figure 6A.
- limitations
- D2 kinetic data came from one experiment; results do not establish human dosing equivalence.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens proteins
- plain_language
- CYP27B1 completes activation of the D2 precursor.
- primary_references
- [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
- tissue_or_cell_type
- reconstituted inner-mitochondrial-membrane model
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 437–450
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Partially purified human CYP27B1 membrane assay · source_derived_draft · unverified_draft
### vd-act-cyp27b1-d2 Human CYP27B1 1alpha-hydroxylated 25-hydroxyvitamin D2 in phospholipid vesicles; low-substrate catalytic efficiency was similar to that measured for calcifediol. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP27B1 completes activation of the D2 precursor. organism: Homo sapiens proteins tissue_or_cell_type: reconstituted inner-mitochondrial-membrane model experimental_model: Partially purified human CYP27B1 membrane assay limitations: D2 kinetic data came from one experiment; results do not establish human dosing equivalence. exposure: 5-40 nM CYP27B1; 15 micromolar FDX1, 0.4 micromolar FDXR, 50 micromolar NADPH; 2 min at 37 C. Table 5/Figure 6A. cross_nutrient: false evidence_location: Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved. nutrient: Vitamin D2 and D3 [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
Complete structured claim and evidenceHuman adrenodoxin supported CYP27B1 activity in reconstituted vesicles; varying adrenodoxin changed apparent kinetic parameters for calcifediol hydroxylation.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved.
- experimental_model
- Human CYP27B1/FDX1/FDXR kinetic reconstitution
- exposure
- FDX1 1-30 micromolar; 2-min incubations with calcifediol; Table 4.
- limitations
- The experiment varies intact FDX1, not dietary iron. Reciprocal changes of apparent Km and turnover prevent interpreting FDX1 level as a universal limiting factor.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens proteins
- plain_language
- An iron-sulfur electron carrier supports the final D3 activation step.
- primary_references
- [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
- tissue_or_cell_type
- reconstituted mitochondrial membrane
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 452–465
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CYP27B1/FDX1/FDXR kinetic reconstitution · source_derived_draft · unverified_draft
### vd-act-fdx1-cyp27b1 Human adrenodoxin supported CYP27B1 activity in reconstituted vesicles; varying adrenodoxin changed apparent kinetic parameters for calcifediol hydroxylation. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: An iron-sulfur electron carrier supports the final D3 activation step. organism: Homo sapiens proteins tissue_or_cell_type: reconstituted mitochondrial membrane experimental_model: Human CYP27B1/FDX1/FDXR kinetic reconstitution limitations: The experiment varies intact FDX1, not dietary iron. Reciprocal changes of apparent Km and turnover prevent interpreting FDX1 level as a universal limiting factor. exposure: FDX1 1-30 micromolar; 2-min incubations with calcifediol; Table 4. cross_nutrient: true evidence_location: Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved. nutrient: Vitamin D2 and D3 [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
Complete structured claim and evidenceThe active human CYP27B1 reconstitution supplied human adrenodoxin reductase and NADPH upstream of human adrenodoxin.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved.
- experimental_model
- Human protein reconstitution and substrate turnover
- exposure
- 0.4 micromolar FDXR, 15 micromolar FDX1 and 50 micromolar NADPH; Experimental procedures.
- limitations
- This record reports the supported redox chain; FDXR omission or dietary niacin/riboflavin intervention was not reported in the extracted experiment.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens proteins
- plain_language
- A reductase feeds the electron carrier used during vitamin D activation.
- primary_references
- [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
- tissue_or_cell_type
- mitochondrial redox-partner assay
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 467–480
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human protein reconstitution and substrate turnover · source_derived_draft · unverified_draft
### vd-act-fdxr-cyp27b1-system The active human CYP27B1 reconstitution supplied human adrenodoxin reductase and NADPH upstream of human adrenodoxin. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A reductase feeds the electron carrier used during vitamin D activation. organism: Homo sapiens proteins tissue_or_cell_type: mitochondrial redox-partner assay experimental_model: Human protein reconstitution and substrate turnover limitations: This record reports the supported redox chain; FDXR omission or dietary niacin/riboflavin intervention was not reported in the extracted experiment. exposure: 0.4 micromolar FDXR, 15 micromolar FDX1 and 50 micromolar NADPH; Experimental procedures. cross_nutrient: true evidence_location: Primary Tables 3-5, Figure 6A and Experimental procedures; full text retrieved. nutrient: Vitamin D2 and D3 [tang2012] Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. (2012). https://pubmed.ncbi.nlm.nih.gov/22862690/ DOI: 10.1111/j.1742-4658.2012.08736.x
Complete structured claim and evidenceHuman POR supported CYP2R1-mediated cholecalciferol 25-hydroxylation, with maximal measured activity near a 4:1 POR:CYP2R1 molar ratio.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Primary Figure 2C; Methods 2.3 and reconstitution assays.
- experimental_model
- Purified enzyme and phospholipid-vesicle reconstitution
- exposure
- 0.25 micromolar CYP2R1; varied POR; 30 min at 37 C; Figure 2C.
- limitations
- Assay optimum is not a tissue expression target or a vitamin dosing requirement.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens proteins
- plain_language
- CYP2R1 needs an electron-supplying partner.
- primary_references
- [cheng2018] Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3. (2018). https://pubmed.ncbi.nlm.nih.gov/28716760/ DOI: 10.1016/j.jsbmb.2017.07.011
- tissue_or_cell_type
- reconstituted membrane
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 392–405
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified enzyme and phospholipid-vesicle reconstitution · source_derived_draft · unverified_draft
### vd-act-por-support Human POR supported CYP2R1-mediated cholecalciferol 25-hydroxylation, with maximal measured activity near a 4:1 POR:CYP2R1 molar ratio. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP2R1 needs an electron-supplying partner. organism: Homo sapiens proteins tissue_or_cell_type: reconstituted membrane experimental_model: Purified enzyme and phospholipid-vesicle reconstitution limitations: Assay optimum is not a tissue expression target or a vitamin dosing requirement. exposure: 0.25 micromolar CYP2R1; varied POR; 30 min at 37 C; Figure 2C. cross_nutrient: true evidence_location: Primary Figure 2C; Methods 2.3 and reconstitution assays. nutrient: Vitamin D2 and D3 [cheng2018] Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3. (2018). https://pubmed.ncbi.nlm.nih.gov/28716760/ DOI: 10.1016/j.jsbmb.2017.07.011
Complete structured claim and evidenceRecombinant human CYP1A1 catalyzed melatonin 6-hydroxylation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"}
- experimental_model
- Recombinant P450 screen and mouse brain comparisons
- exposure
- Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation
- limitations
- Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human recombinant enzymes; separate mouse knockout experiment
- plain_language
- Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue.
- primary_references
- [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
- tissue_or_cell_type
- Oxidative melatonin metabolism
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 565–576
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant P450 screen and mouse brain comparisons · source_derived_draft · unverified_draft
### melatonin-cyp-1a1-hydroxylation Recombinant human CYP1A1 catalyzed melatonin 6-hydroxylation. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue. organism: Human recombinant enzymes; separate mouse knockout experiment tissue_or_cell_type: Oxidative melatonin metabolism experimental_model: Recombinant P450 screen and mouse brain comparisons limitations: Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity. exposure: Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation evidence_span: {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"} [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
Complete structured claim and evidenceHuman CYP1A2 catalyzed melatonin O-demethylation to a lesser extent than CYP2C19 in the study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"}
- experimental_model
- Recombinant P450 screen and mouse brain comparisons
- exposure
- Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation
- limitations
- Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human recombinant enzymes; separate mouse knockout experiment
- plain_language
- Removing the methyl group returns a molecule with the identity of a synthetic precursor.
- primary_references
- [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
- tissue_or_cell_type
- Oxidative melatonin metabolism
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 617–628
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant P450 screen and mouse brain comparisons · source_derived_draft · unverified_draft
### melatonin-cyp-1a2-demethylation Human CYP1A2 catalyzed melatonin O-demethylation to a lesser extent than CYP2C19 in the study. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Removing the methyl group returns a molecule with the identity of a synthetic precursor. organism: Human recombinant enzymes; separate mouse knockout experiment tissue_or_cell_type: Oxidative melatonin metabolism experimental_model: Recombinant P450 screen and mouse brain comparisons limitations: Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity. exposure: Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation evidence_span: {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"} [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
Complete structured claim and evidenceRecombinant human CYP1B1 catalyzed melatonin 6-hydroxylation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"}
- experimental_model
- Recombinant P450 screen and mouse brain comparisons
- exposure
- Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation
- limitations
- Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human recombinant enzymes; separate mouse knockout experiment
- plain_language
- Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue.
- primary_references
- [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
- tissue_or_cell_type
- Oxidative melatonin metabolism
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 578–589
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant P450 screen and mouse brain comparisons · source_derived_draft · unverified_draft
### melatonin-cyp-1b1-hydroxylation Recombinant human CYP1B1 catalyzed melatonin 6-hydroxylation. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue. organism: Human recombinant enzymes; separate mouse knockout experiment tissue_or_cell_type: Oxidative melatonin metabolism experimental_model: Recombinant P450 screen and mouse brain comparisons limitations: Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity. exposure: Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation evidence_span: {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"} [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
Complete structured claim and evidenceHuman CYP2C19 catalyzed melatonin O-demethylation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"}
- experimental_model
- Recombinant P450 screen and mouse brain comparisons
- exposure
- Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation
- limitations
- Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human recombinant enzymes; separate mouse knockout experiment
- plain_language
- Removing the methyl group returns a molecule with the identity of a synthetic precursor.
- primary_references
- [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
- tissue_or_cell_type
- Oxidative melatonin metabolism
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 604–615
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant P450 screen and mouse brain comparisons · source_derived_draft · unverified_draft
### melatonin-cyp-2c19-demethylation Human CYP2C19 catalyzed melatonin O-demethylation. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Removing the methyl group returns a molecule with the identity of a synthetic precursor. organism: Human recombinant enzymes; separate mouse knockout experiment tissue_or_cell_type: Oxidative melatonin metabolism experimental_model: Recombinant P450 screen and mouse brain comparisons limitations: Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity. exposure: Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation evidence_span: {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"} [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
Complete structured claim and evidenceRecombinant human CYP2C19 catalyzed melatonin 6-hydroxylation to a minor extent in this screen.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"}
- experimental_model
- Recombinant P450 screen and mouse brain comparisons
- exposure
- Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation
- limitations
- Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human recombinant enzymes; separate mouse knockout experiment
- plain_language
- Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue.
- primary_references
- [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
- tissue_or_cell_type
- Oxidative melatonin metabolism
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 591–602
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant P450 screen and mouse brain comparisons · source_derived_draft · unverified_draft
### melatonin-cyp-2c19-hydroxylation Recombinant human CYP2C19 catalyzed melatonin 6-hydroxylation to a minor extent in this screen. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Melatonin has multiple metabolic routes whose importance depends on enzyme and tissue. organism: Human recombinant enzymes; separate mouse knockout experiment tissue_or_cell_type: Oxidative melatonin metabolism experimental_model: Recombinant P450 screen and mouse brain comparisons limitations: Catalytic capacity in an enzyme assay is not whole-body contribution. CYP1B1 is an extrahepatic route; human proteins are not substituted for mouse knockout identity. exposure: Eleven P450 isozymes; NADPH-dependent 6-hydroxylation/O-demethylation evidence_span: {"source_cache": "artifacts/melatonin-research/15616152.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2", "start_char": 0, "end_char": 1733, "text_sha256": "482334074e10503323360f236e00b5b837c5b082a7cda4df000a23d491bff8a2"} [melatonin-p15616152] Metabolism of melatonin by human cytochromes p450. (2005). https://pubmed.ncbi.nlm.nih.gov/15616152/ DOI: 10.1124/dmd.104.002410
Complete structured claim and evidenceA vanadate/ascorbate/phosphate system oxidized NADH, with similar results for NADPH, through a proposed superoxide-initiated chain reaction.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free NADH/NADPH oxidation experiments.
- limitations
- Not evidence of a measured whole-body NAD shortage.
- nutrient_topic
- Vanadium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Vanadium
- plain_language
- Reducing equivalents can be consumed by a metal-dependent reaction.
- primary_references
- Vanadate-mediated oxidation of NADH: description of an in vitro system requiring ascorbate and phosphate. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2735768/ · DOI 10.1016/0003-9861(89)90196-3
Vanadium: speciation, phosphate-sensitive enzymes and cross-nutrient mechanisms (2026-09-19) · lines 118–124
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free NADH/NADPH oxidation experiments. · source_derived_draft · unverified_draft
## vanadium-nadh-oxidation Reducing equivalents can be consumed by a metal-dependent reaction. A vanadate/ascorbate/phosphate system oxidized NADH, with similar results for NADPH, through a proposed superoxide-initiated chain reaction. Model: Cell-free NADH/NADPH oxidation experiments. Limitations: Not evidence of a measured whole-body NAD shortage. Evidence access: Primary abstract Vanadate-mediated oxidation of NADH: description of an in vitro system requiring ascorbate and phosphate. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2735768/ · DOI 10.1016/0003-9861(89)90196-3
Complete structured claim and evidenceCOQ6 substrate conversion required the FDXR-FDX2 pair in the reconstructed assay.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/coq10-research/38425362.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d25af4ecd7340649536b8fea3b8a0a308a1611bbf8c57f6a79b362f443f1cba", "start_char": 9067, "end_char": 13813, "text_sha256": "49612ae4d3a59a75a02fe3fb132abd8aeb7ef8b7cae3b0f79b5557503c55ad51"}
- experimental_model
- Purified reconstructed COQ metabolon with short-chain substrates
- exposure
- Enzyme combinations, methyl donors, reductants and metal additions
- limitations
- Ancestral proteins and CoQ1 analogues; no clinical cofactor dose or proof of nutritional rate limitation. Reaction order need not be universal across species.
- nutrient_topic
- Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. · Coenzyme Q10 / CoQ10 redox system
- organism
- Reconstructed ancestral tetrapod proteins
- plain_language
- The monooxygenase needed its electron-supplying partners.
- primary_references
- [coq10-p38425362] In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis. (2024). https://pubmed.ncbi.nlm.nih.gov/38425362/ DOI: 10.1038/s41929-023-01087-z
- tissue_or_cell_type
- Stepwise CoQ head-group assembly
Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17) · lines 632–643
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified reconstructed COQ metabolon with short-chain substrates · source_derived_draft · unverified_draft
### coq10-fdx2-coq6 COQ6 substrate conversion required the FDXR-FDX2 pair in the reconstructed assay. Condition category: normal nutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The monooxygenase needed its electron-supplying partners. organism: Reconstructed ancestral tetrapod proteins tissue_or_cell_type: Stepwise CoQ head-group assembly experimental_model: Purified reconstructed COQ metabolon with short-chain substrates limitations: Ancestral proteins and CoQ1 analogues; no clinical cofactor dose or proof of nutritional rate limitation. Reaction order need not be universal across species. exposure: Enzyme combinations, methyl donors, reductants and metal additions evidence_span: {"source_cache": "artifacts/coq10-research/38425362.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d25af4ecd7340649536b8fea3b8a0a308a1611bbf8c57f6a79b362f443f1cba", "start_char": 9067, "end_char": 13813, "text_sha256": "49612ae4d3a59a75a02fe3fb132abd8aeb7ef8b7cae3b0f79b5557503c55ad51"} [coq10-p38425362] In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis. (2024). https://pubmed.ncbi.nlm.nih.gov/38425362/ DOI: 10.1038/s41929-023-01087-z
Complete structured claim and evidenceFDX2 accepted electrons from reduced FDXR in the reconstructed system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/coq10-research/38425362.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d25af4ecd7340649536b8fea3b8a0a308a1611bbf8c57f6a79b362f443f1cba", "start_char": 9067, "end_char": 13813, "text_sha256": "49612ae4d3a59a75a02fe3fb132abd8aeb7ef8b7cae3b0f79b5557503c55ad51"}
- experimental_model
- Purified reconstructed COQ metabolon with short-chain substrates
- exposure
- Enzyme combinations, methyl donors, reductants and metal additions
- limitations
- Ancestral proteins and CoQ1 analogues; no clinical cofactor dose or proof of nutritional rate limitation. Reaction order need not be universal across species.
- nutrient_topic
- Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. · Coenzyme Q10 / CoQ10 redox system
- organism
- Reconstructed ancestral tetrapod proteins
- plain_language
- The synthesis pathway has a separate relay supplying reducing power.
- primary_references
- [coq10-p38425362] In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis. (2024). https://pubmed.ncbi.nlm.nih.gov/38425362/ DOI: 10.1038/s41929-023-01087-z
- tissue_or_cell_type
- Stepwise CoQ head-group assembly
Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17) · lines 619–630
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified reconstructed COQ metabolon with short-chain substrates · source_derived_draft · unverified_draft
### coq10-fdxr-fdx2 FDX2 accepted electrons from reduced FDXR in the reconstructed system. Condition category: normal nutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The synthesis pathway has a separate relay supplying reducing power. organism: Reconstructed ancestral tetrapod proteins tissue_or_cell_type: Stepwise CoQ head-group assembly experimental_model: Purified reconstructed COQ metabolon with short-chain substrates limitations: Ancestral proteins and CoQ1 analogues; no clinical cofactor dose or proof of nutritional rate limitation. Reaction order need not be universal across species. exposure: Enzyme combinations, methyl donors, reductants and metal additions evidence_span: {"source_cache": "artifacts/coq10-research/38425362.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7d25af4ecd7340649536b8fea3b8a0a308a1611bbf8c57f6a79b362f443f1cba", "start_char": 9067, "end_char": 13813, "text_sha256": "49612ae4d3a59a75a02fe3fb132abd8aeb7ef8b7cae3b0f79b5557503c55ad51"} [coq10-p38425362] In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis. (2024). https://pubmed.ncbi.nlm.nih.gov/38425362/ DOI: 10.1038/s41929-023-01087-z
Complete structured claim and evidenceMammalian TrxR1 reduced ubiquinone-10 to ubiquinol-10.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/coq10-research/12435734.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "929e8de2bc15ea62eb4a3814995fd289de759d721f16b848174ad65f95847c55", "start_char": 0, "end_char": 1340, "text_sha256": "929e8de2bc15ea62eb4a3814995fd289de759d721f16b848174ad65f95847c55"}
- experimental_model
- Enzyme kinetics, mutants and overexpressing-cell homogenates
- exposure
- NADPH or NADH; selenite and selenium-deprived enzyme variants
- limitations
- Biochemical selenium dependence; not proof that all CoQ recycling stops with low selenium or that combined supplements are synergistic clinically.
- nutrient_topic
- Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. · Coenzyme Q10 / CoQ10 redox system
- organism
- Mammalian TrxR1 and human HEK293 cells
- plain_language
- A selenium-dependent enzyme can regenerate the antioxidant form of CoQ.
- primary_references
- [coq10-p12435734] The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/12435734/ DOI: 10.1074/jbc.m210456200
- tissue_or_cell_type
- Ubiquinone reduction
Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17) · lines 762–773
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Enzyme kinetics, mutants and overexpressing-cell homogenates · source_derived_draft · unverified_draft
### coq10-txnrd1-coq Mammalian TrxR1 reduced ubiquinone-10 to ubiquinol-10. Condition category: normal nutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A selenium-dependent enzyme can regenerate the antioxidant form of CoQ. organism: Mammalian TrxR1 and human HEK293 cells tissue_or_cell_type: Ubiquinone reduction experimental_model: Enzyme kinetics, mutants and overexpressing-cell homogenates limitations: Biochemical selenium dependence; not proof that all CoQ recycling stops with low selenium or that combined supplements are synergistic clinically. exposure: NADPH or NADH; selenite and selenium-deprived enzyme variants evidence_span: {"source_cache": "artifacts/coq10-research/12435734.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "929e8de2bc15ea62eb4a3814995fd289de759d721f16b848174ad65f95847c55", "start_char": 0, "end_char": 1340, "text_sha256": "929e8de2bc15ea62eb4a3814995fd289de759d721f16b848174ad65f95847c55"} [coq10-p12435734] The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/12435734/ DOI: 10.1074/jbc.m210456200
Complete structured claim and evidenceCybb/gp91phox-deficient macrophages retained silica-triggered inflammasome responses.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Mouse macrophage genetic comparison.
- limitations
- Does not exclude every ROS source or establish NADPH depletion. Correction record: A 2026 author correction replaces an erroneously duplicated lower-left Fig. 8c micrograph with the retrieved original. This is a figure correction, not a scientific contradiction or retraction. https://www.nature.com/articles/s41590-026-02468-9
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The phagocyte NADPH oxidase burst was not obligatory in this model.
- primary_references
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18604214/ · DOI 10.1038/ni.1631
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 456–462
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse macrophage genetic comparison. · source_derived_draft · unverified_draft
## silica-nox2-null The phagocyte NADPH oxidase burst was not obligatory in this model. Cybb/gp91phox-deficient macrophages retained silica-triggered inflammasome responses. Model: Mouse macrophage genetic comparison. Limitations: Does not exclude every ROS source or establish NADPH depletion. Correction record: A 2026 author correction replaces an erroneously duplicated lower-left Fig. 8c micrograph with the retrieved original. This is a figure correction, not a scientific contradiction or retraction. https://www.nature.com/articles/s41590-026-02468-9 Evidence access: Primary full text Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18604214/ · DOI 10.1038/ni.1631
Complete structured claim and evidenceHEK293T cells coexpressing bovine RGR and RDH10 generated more 11-cis-retinol from all-trans-retinol during illumination than cells expressing either protein alone.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Figure 1A; STAR Methods: Expression of RGR and RDH10
- experimental_model
- Recombinant bovine RGR/RDH10 coexpression
- exposure
- 30-minute illumination; 5 micromolar all-trans-retinol; assay medium contained 250 micromolar NADPH.
- limitations
- Coupled output does not prove every proposed intermediate reaction or RDH10 necessity in intact retina. Added NADPH is an assay component, not a demonstrated dietary requirement.
- nutrient
- Vitamin A · Vitamin A
- nutrient_topic
- Vitamin A expansion research collection; topical membership is not evidence of a direct dietary effect. · Vitamin A
- organism
- Bos taurus proteins in Homo sapiens cells
- plain_language
- The two proteins supported light-dependent retinol recycling together in cultured cells.
- primary_references
- [vav-morshedian2019] Light-Driven Regeneration of Cone Visual Pigments through a Mechanism Involving RGR Opsin in Müller Glial Cells. (2019). https://pubmed.ncbi.nlm.nih.gov/31056353/ DOI: 10.1016/j.neuron.2019.04.004
- tissue_or_cell_type
- HEK293T culture
Vitamin A expansion: reproduction, light-driven vision and shared mechanisms (2026-09-17) · lines 468–481
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant bovine RGR/RDH10 coexpression · source_derived_draft · unverified_draft
### vae-rgr-rdh10-coupled-retinol HEK293T cells coexpressing bovine RGR and RDH10 generated more 11-cis-retinol from all-trans-retinol during illumination than cells expressing either protein alone. Condition category: normal nutrient_topic: Vitamin A expansion research collection; topical membership is not evidence of a direct dietary effect. plain_language: The two proteins supported light-dependent retinol recycling together in cultured cells. organism: Bos taurus proteins in Homo sapiens cells tissue_or_cell_type: HEK293T culture experimental_model: Recombinant bovine RGR/RDH10 coexpression limitations: Coupled output does not prove every proposed intermediate reaction or RDH10 necessity in intact retina. Added NADPH is an assay component, not a demonstrated dietary requirement. exposure: 30-minute illumination; 5 micromolar all-trans-retinol; assay medium contained 250 micromolar NADPH. cross_nutrient: false evidence_location: Figure 1A; STAR Methods: Expression of RGR and RDH10 nutrient: Vitamin A [vav-morshedian2019] Light-Driven Regeneration of Cone Visual Pigments through a Mechanism Involving RGR Opsin in Müller Glial Cells. (2019). https://pubmed.ncbi.nlm.nih.gov/31056353/ DOI: 10.1016/j.neuron.2019.04.004
Complete structured claim and evidenceCinnamaldehyde inhibited recombinant human CYP2A6, with reported IC50 6.1 micromolar; inhibition increased with time and required NADPH.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ceylon-research/26851241.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2", "start_char": 0, "end_char": 1591, "text_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2"}
- experimental_model
- Recombinant human CYP assays and mechanistic static modeling
- exposure
- Cinnamaldehyde, NADPH and glutathione; modeled inhibitor concentrations 0.1 and 1 micromolar
- limitations
- Enzyme inhibition and model predictions are not measured clinical drug interactions. NADPH omission is not dietary niacin deficiency.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Human enzyme preparations; computational model
- plain_language
- The chemical interfered with a drug-metabolizing enzyme when its catalytic system was operating.
- primary_references
- [ceylon-p26851241] Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. (2016). https://pubmed.ncbi.nlm.nih.gov/26851241/ DOI: 10.1124/dmd.115.067942
- tissue_or_cell_type
- CYP2A6 reaction system
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 727–738
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human CYP assays and mechanistic static modeling · source_derived_draft · unverified_draft
### ceylon-cyp2a6 Cinnamaldehyde inhibited recombinant human CYP2A6, with reported IC50 6.1 micromolar; inhibition increased with time and required NADPH. Condition category: normal nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: The chemical interfered with a drug-metabolizing enzyme when its catalytic system was operating. organism: Human enzyme preparations; computational model tissue_or_cell_type: CYP2A6 reaction system experimental_model: Recombinant human CYP assays and mechanistic static modeling limitations: Enzyme inhibition and model predictions are not measured clinical drug interactions. NADPH omission is not dietary niacin deficiency. exposure: Cinnamaldehyde, NADPH and glutathione; modeled inhibitor concentrations 0.1 and 1 micromolar evidence_span: {"source_cache": "artifacts/ceylon-research/26851241.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2", "start_char": 0, "end_char": 1591, "text_sha256": "c2fb6b18a3ba708f060d53011ea0e198f98fe980930297e714c488a41413b5a2"} [ceylon-p26851241] Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. (2016). https://pubmed.ncbi.nlm.nih.gov/26851241/ DOI: 10.1124/dmd.115.067942
Complete structured claim and evidenceThe three 2012 red yeast rice product extracts inhibited human microsomal CYP1A2 more potently than pure lovastatin at matched nominal lovastatin concentrations.
Experimental context and source evidence
- evidence_access
- Primary full text PMC3513969, CYP methods and results
- experimental_model
- Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system.
- limitations
- In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The mixture changed an enzyme assay beyond its lovastatin content.
- primary_references
- [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 108–114
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. · source_derived_draft · unverified_draft
## red-yeast-rice-extract-cyp1a2 The mixture changed an enzyme assay beyond its lovastatin content. The three 2012 red yeast rice product extracts inhibited human microsomal CYP1A2 more potently than pure lovastatin at matched nominal lovastatin concentrations. Model: Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. Limitations: In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified. Evidence access: Primary full text PMC3513969, CYP methods and results [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Complete structured claim and evidenceThe three 2012 red yeast rice product extracts inhibited human microsomal CYP2C19 more potently than pure lovastatin at matched nominal lovastatin concentrations.
Experimental context and source evidence
- evidence_access
- Primary full text PMC3513969, CYP methods and results
- experimental_model
- Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system.
- limitations
- In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The mixture changed an enzyme assay beyond its lovastatin content.
- primary_references
- [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 116–122
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. · source_derived_draft · unverified_draft
## red-yeast-rice-extract-cyp2c19 The mixture changed an enzyme assay beyond its lovastatin content. The three 2012 red yeast rice product extracts inhibited human microsomal CYP2C19 more potently than pure lovastatin at matched nominal lovastatin concentrations. Model: Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. Limitations: In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified. Evidence access: Primary full text PMC3513969, CYP methods and results [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Complete structured claim and evidenceThe three 2012 red yeast rice product extracts inhibited human microsomal CYP3A4 more potently than pure lovastatin at matched nominal lovastatin concentrations.
Experimental context and source evidence
- evidence_access
- Primary full text PMC3513969, CYP methods and results
- experimental_model
- Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system.
- limitations
- In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The mixture changed an enzyme assay beyond its lovastatin content.
- primary_references
- [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 124–130
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. · source_derived_draft · unverified_draft
## red-yeast-rice-extract-cyp3a4 The mixture changed an enzyme assay beyond its lovastatin content. The three 2012 red yeast rice product extracts inhibited human microsomal CYP3A4 more potently than pure lovastatin at matched nominal lovastatin concentrations. Model: Human liver microsomes; product concentrations normalized to 0.5–25 micromolar lovastatin, with an NADPH-generating system. Limitations: In-vitro inhibition is not a measured interaction with every drug using this enzyme; the additional responsible constituent was not identified. Evidence access: Primary full text PMC3513969, CYP methods and results [23227093] Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23227093/ · DOI 10.1155/2012/127043
Complete structured claim and evidenceHuman HMG-CoA reductase catalyzes mevalonate formation; substrate/cofactor-bound structures locate HMG-CoA and the nicotinamide cofactor in the catalytic domain.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human recombinant catalytic-domain crystallography and biochemical background.
- limitations
- Shared human machinery; the source is not an experiment administering red yeast rice.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- This enzyme supplies a shared precursor pathway.
- primary_references
- [10698924] Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10698924/ · DOI 10.1093/emboj/19.5.819
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 76–82
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human recombinant catalytic-domain crystallography and biochemical background. · source_derived_draft · unverified_draft
## red-yeast-rice-human-mevalonate-machinery This enzyme supplies a shared precursor pathway. Human HMG-CoA reductase catalyzes mevalonate formation; substrate/cofactor-bound structures locate HMG-CoA and the nicotinamide cofactor in the catalytic domain. Model: Human recombinant catalytic-domain crystallography and biochemical background. Limitations: Shared human machinery; the source is not an experiment administering red yeast rice. Evidence access: Primary abstract [10698924] Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10698924/ · DOI 10.1093/emboj/19.5.819
Complete structured claim and evidenceFSP1 reduced vitamin K quinones to radical-trapping hydroquinones using NAD(P)H.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/k2-research/35922516.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3bd5750fd2d12a754ad4237018851391c6b5b80bac6ad58307321fb7c3042c5a", "start_char": 0, "end_char": 1403, "text_sha256": "3bd5750fd2d12a754ad4237018851391c6b5b80bac6ad58307321fb7c3042c5a"}
- experimental_model
- Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice
- exposure
- MK-4/K1, NAD(P)H, FSP1 loss and inhibitors
- limitations
- Preclinical experiments; not a demonstrated oral MK-7 treatment for ferroptosis-related disease or a self-treatment regimen for anticoagulant poisoning.
- nutrient_topic
- Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin K2 / menaquinone family
- organism
- Human recombinant FSP1, mammalian cells and mice
- plain_language
- A niacin-derived electron donor helps regenerate the reduced antioxidant form.
- primary_references
- [k2-p35922516] A non-canonical vitamin K cycle is a potent ferroptosis suppressor. (2022). https://pubmed.ncbi.nlm.nih.gov/35922516/ DOI: 10.1038/s41586-022-05022-3
- tissue_or_cell_type
- Lipid peroxidation and vitamin K reduction
Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17) · lines 773–784
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice · source_derived_draft · unverified_draft
### k2-fsp1-k-reduction FSP1 reduced vitamin K quinones to radical-trapping hydroquinones using NAD(P)H. Condition category: normal nutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A niacin-derived electron donor helps regenerate the reduced antioxidant form. organism: Human recombinant FSP1, mammalian cells and mice tissue_or_cell_type: Lipid peroxidation and vitamin K reduction experimental_model: Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice limitations: Preclinical experiments; not a demonstrated oral MK-7 treatment for ferroptosis-related disease or a self-treatment regimen for anticoagulant poisoning. exposure: MK-4/K1, NAD(P)H, FSP1 loss and inhibitors evidence_span: {"source_cache": "artifacts/k2-research/35922516.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3bd5750fd2d12a754ad4237018851391c6b5b80bac6ad58307321fb7c3042c5a", "start_char": 0, "end_char": 1403, "text_sha256": "3bd5750fd2d12a754ad4237018851391c6b5b80bac6ad58307321fb7c3042c5a"} [k2-p35922516] A non-canonical vitamin K cycle is a potent ferroptosis suppressor. (2022). https://pubmed.ncbi.nlm.nih.gov/35922516/ DOI: 10.1038/s41586-022-05022-3
Complete structured claim and evidenceCurA catalyzed the first reduction of curcumin to dihydrocurcumin.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"}
- experimental_model
- Purification and characterization of a human-fecal bacterial enzyme
- exposure
- Curcumin and reduced intermediates; NADPH-dependent reactions
- limitations
- Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Escherichia coli isolate
- plain_language
- A gut bacterial enzyme performs the first reduction step.
- primary_references
- [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
- tissue_or_cell_type
- Purified CurA
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 203–214
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purification and characterization of a human-fecal bacterial enzyme · source_derived_draft · unverified_draft
### curcumin-cura-first CurA catalyzed the first reduction of curcumin to dihydrocurcumin. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A gut bacterial enzyme performs the first reduction step. organism: Escherichia coli isolate tissue_or_cell_type: Purified CurA experimental_model: Purification and characterization of a human-fecal bacterial enzyme limitations: Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion. exposure: Curcumin and reduced intermediates; NADPH-dependent reactions evidence_span: {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"} [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
Complete structured claim and evidenceCurA then reduced dihydrocurcumin to tetrahydrocurcumin.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"}
- experimental_model
- Purification and characterization of a human-fecal bacterial enzyme
- exposure
- Curcumin and reduced intermediates; NADPH-dependent reactions
- limitations
- Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Escherichia coli isolate
- plain_language
- The same enzyme can carry out the next step.
- primary_references
- [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
- tissue_or_cell_type
- Purified CurA
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 216–227
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purification and characterization of a human-fecal bacterial enzyme · source_derived_draft · unverified_draft
### curcumin-cura-second CurA then reduced dihydrocurcumin to tetrahydrocurcumin. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same enzyme can carry out the next step. organism: Escherichia coli isolate tissue_or_cell_type: Purified CurA experimental_model: Purification and characterization of a human-fecal bacterial enzyme limitations: Bacterial biochemistry does not quantify a person's circulating metabolite concentrations or establish that dietary niacin increases this conversion. exposure: Curcumin and reduced intermediates; NADPH-dependent reactions evidence_span: {"source_cache": "artifacts/curcumin-research/21467222.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757", "start_char": 0, "end_char": 1325, "text_sha256": "c4ff0be81d2a3b3bd5edb9902da02b1e599d45a5e60ab4787514e340bf63d757"} [curcumin-p21467222] Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. (2011). https://pubmed.ncbi.nlm.nih.gov/21467222/ DOI: 10.1073/pnas.1016217108
Complete structured claim and evidenceMass spectrometry and blotting supported modification of Cys496 and Sec497 in the rat enzyme.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"}
- experimental_model
- Purified rat enzyme and separate HeLa-cell assays
- exposure
- Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar
- limitations
- Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Rattus norvegicus
- plain_language
- The interaction included the selenium-containing active-site residue.
- primary_references
- [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
- tissue_or_cell_type
- Purified enzyme
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 515–526
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat enzyme and separate HeLa-cell assays · source_derived_draft · unverified_draft
### curcumin-trx-adduct Mass spectrometry and blotting supported modification of Cys496 and Sec497 in the rat enzyme. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The interaction included the selenium-containing active-site residue. organism: Rattus norvegicus tissue_or_cell_type: Purified enzyme experimental_model: Purified rat enzyme and separate HeLa-cell assays limitations: Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit. exposure: Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar evidence_span: {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"} [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
Complete structured claim and evidenceCurcumin inhibited NADPH-reduced rat TrxR1 and inhibition persisted after curcumin removal.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"}
- experimental_model
- Purified rat enzyme and separate HeLa-cell assays
- exposure
- Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar
- limitations
- Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Rattus norvegicus
- plain_language
- An enzyme that normally helps control oxidation was inhibited.
- primary_references
- [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
- tissue_or_cell_type
- Purified enzyme
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 502–513
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat enzyme and separate HeLa-cell assays · source_derived_draft · unverified_draft
### curcumin-trx-inhibition Curcumin inhibited NADPH-reduced rat TrxR1 and inhibition persisted after curcumin removal. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: An enzyme that normally helps control oxidation was inhibited. organism: Rattus norvegicus tissue_or_cell_type: Purified enzyme experimental_model: Purified rat enzyme and separate HeLa-cell assays limitations: Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit. exposure: Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar evidence_span: {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"} [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
Complete structured claim and evidenceThe modified enzyme acquired increased NADPH oxidase activity associated with reactive oxygen species production.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"}
- experimental_model
- Purified rat enzyme and separate HeLa-cell assays
- exposure
- Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar
- limitations
- Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Rattus norvegicus
- plain_language
- The modified protein could consume reducing power while promoting oxidation.
- primary_references
- [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
- tissue_or_cell_type
- Purified enzyme
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 528–539
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat enzyme and separate HeLa-cell assays · source_derived_draft · unverified_draft
### curcumin-trx-oxidase The modified enzyme acquired increased NADPH oxidase activity associated with reactive oxygen species production. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The modified protein could consume reducing power while promoting oxidation. organism: Rattus norvegicus tissue_or_cell_type: Purified enzyme experimental_model: Purified rat enzyme and separate HeLa-cell assays limitations: Rat residue numbering Cys496/Sec497 is source-specific and must not replace numbering in other TrxR constructs. Cellular enzyme activity does not prove clinical cancer benefit. exposure: Rat enzyme: two-hour incubation, IC50 3.6 micromolar; HeLa activity IC50 about 15 micromolar evidence_span: {"source_cache": "artifacts/curcumin-research/15879598.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c", "start_char": 0, "end_char": 1659, "text_sha256": "be68f9ed2b0741db356a6bc020304fe832121f92dfd9c423ce8a305e984e995c"} [curcumin-p15879598] Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. (2005). https://pubmed.ncbi.nlm.nih.gov/15879598/ DOI: 10.1074/jbc.m414645200
Complete structured claim and evidenceGSR reduces one glutathione-disulfide molecule to two reduced glutathione molecules using the NADPH/FAD catalytic relay.
Experimental context and source evidence
- cross_nutrient
- B2-FAD supports GSH recycling; selenium-dependent GPX use of GSH is a separate reaction.
- evidence_location
- Results: NADPH binding; Fig 1 consensus cycle; GSH/GSSG complexes
- experimental_model
- Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls.
- exposure
- Purified-enzyme assay
- limitations
- GSR is not glutathione peroxidase; this record does not show that B2 improves selenium repletion.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- This enzyme recycles glutathione after oxidation.
- primary_references
- [berkholz2008] Catalytic cycle of human glutathione reductase near 1 A resolution. (2008). https://pubmed.ncbi.nlm.nih.gov/18638483/ DOI: 10.1016/j.jmb.2008.06.083
- tissue_or_cell_type
- Purified human GSR
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1332–1344
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls. · source_derived_draft · unverified_draft
### b2-gsr-gssg-to-gsh GSR reduces one glutathione-disulfide molecule to two reduced glutathione molecules using the NADPH/FAD catalytic relay. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: This enzyme recycles glutathione after oxidation. organism: Homo sapiens tissue_or_cell_type: Purified human GSR experimental_model: Purified human glutathione reductase crystals with natural substrates, 0.95-1.1-A resolution, chemically reduced controls. limitations: GSR is not glutathione peroxidase; this record does not show that B2 improves selenium repletion. exposure: Purified-enzyme assay cross_nutrient: B2-FAD supports GSH recycling; selenium-dependent GPX use of GSH is a separate reaction. evidence_location: Results: NADPH binding; Fig 1 consensus cycle; GSH/GSSG complexes [berkholz2008] Catalytic cycle of human glutathione reductase near 1 A resolution. (2008). https://pubmed.ncbi.nlm.nih.gov/18638483/ DOI: 10.1016/j.jmb.2008.06.083
Complete structured claim and evidenceHuman KMO membrane assays measured kynurenine conversion to 3-hydroxykynurenine with NADPH; at 200 micromolar NADPH, kynurenine Km was 2 micromolar.
Experimental context and source evidence
- cross_nutrient
- B2-FAD and nicotinamide-containing NADPH support a branch upstream of de novo niacin synthesis.
- evidence_location
- Fig 2f and Methods: kinetic assays; interpret species separately
- experimental_model
- Human KMO in Sf9 membrane preparations; mass-spectrometry kinetics; separate P. fluorescens KMO crystallography.
- exposure
- Purified-enzyme assay
- limitations
- Human functional assays and bacterial structures are distinct evidence; this experiment did not test dietary B2 restriction or total NAD synthesis.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- A flavin enzyme directs tryptophan-derived kynurenine into the hydroxylated branch.
- primary_references
- [hutchinson2017] Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. (2017). https://pubmed.ncbi.nlm.nih.gov/28604669/ DOI: 10.1038/ncomms15827
- tissue_or_cell_type
- Sf9 membrane fraction expressing human KMO
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1234–1246
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human KMO in Sf9 membrane preparations; mass-spectrometry kinetics; separate P. fluorescens KMO crystallography. · source_derived_draft · unverified_draft
### b2-kmo-kynurenine-hydroxylation Human KMO membrane assays measured kynurenine conversion to 3-hydroxykynurenine with NADPH; at 200 micromolar NADPH, kynurenine Km was 2 micromolar. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A flavin enzyme directs tryptophan-derived kynurenine into the hydroxylated branch. organism: Homo sapiens tissue_or_cell_type: Sf9 membrane fraction expressing human KMO experimental_model: Human KMO in Sf9 membrane preparations; mass-spectrometry kinetics; separate P. fluorescens KMO crystallography. limitations: Human functional assays and bacterial structures are distinct evidence; this experiment did not test dietary B2 restriction or total NAD synthesis. exposure: Purified-enzyme assay cross_nutrient: B2-FAD and nicotinamide-containing NADPH support a branch upstream of de novo niacin synthesis. evidence_location: Fig 2f and Methods: kinetic assays; interpret species separately [hutchinson2017] Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. (2017). https://pubmed.ncbi.nlm.nih.gov/28604669/ DOI: 10.1038/ncomms15827
Complete structured claim and evidenceHPLC assays measured human MTHFR reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate using NADPH.
Experimental context and source evidence
- cross_nutrient
- B2-FAD, folate and nicotinamide-containing NADPH participate in one reaction.
- evidence_location
- Results: kinetics, FAD occupancy and SAM inhibition; Table 1; Figs 2-4, 6
- experimental_model
- Recombinant human MTHFR expressed in Sf9 cells; mass spectrometry, 2.5-A structure, HPLC activity assays.
- exposure
- Purified-enzyme assay
- limitations
- Biochemical evidence does not establish a dietary threshold or supplementation benefit.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- The enzyme makes the methylfolate used in homocysteine recycling.
- primary_references
- [froese2018] Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition. (2018). https://pubmed.ncbi.nlm.nih.gov/29891918/ DOI: 10.1038/s41467-018-04735-2
- tissue_or_cell_type
- Purified recombinant enzyme; no intact tissue
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1010–1022
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MTHFR expressed in Sf9 cells; mass spectrometry, 2.5-A structure, HPLC activity assays. · source_derived_draft · unverified_draft
### b2-mthfr-methylfolate-production HPLC assays measured human MTHFR reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate using NADPH. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The enzyme makes the methylfolate used in homocysteine recycling. organism: Homo sapiens tissue_or_cell_type: Purified recombinant enzyme; no intact tissue experimental_model: Recombinant human MTHFR expressed in Sf9 cells; mass spectrometry, 2.5-A structure, HPLC activity assays. limitations: Biochemical evidence does not establish a dietary threshold or supplementation benefit. exposure: Purified-enzyme assay cross_nutrient: B2-FAD, folate and nicotinamide-containing NADPH participate in one reaction. evidence_location: Results: kinetics, FAD occupancy and SAM inhibition; Table 1; Figs 2-4, 6 [froese2018] Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition. (2018). https://pubmed.ncbi.nlm.nih.gov/29891918/ DOI: 10.1038/s41467-018-04735-2
Complete structured claim and evidenceReconstituted assays showed human MTRR sufficient to support NADPH-dependent activity of cobalamin-dependent methionine synthase.
Experimental context and source evidence
- cross_nutrient
- B2 flavins support reactivation of B12-dependent folate/homocysteine metabolism.
- evidence_location
- Abstract
- experimental_model
- Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution.
- exposure
- Purified-enzyme assay
- limitations
- Reconstituted biochemistry; the accessible abstract identifies human MTRR but not the target MTR species. No dietary B2/B12 synergy was tested.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Homo sapiens
- plain_language
- The flavin reductase helps restore an enzyme that uses B12 and methylfolate.
- primary_references
- [olteanu2001] Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. (2001). https://pubmed.ncbi.nlm.nih.gov/11466310/ DOI: 10.1074/jbc.m103707200
- tissue_or_cell_type
- Purified recombinant enzyme; no intact tissue
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1122–1134
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution. · source_derived_draft · unverified_draft
### b2-mtrr-mtr-reactivation Reconstituted assays showed human MTRR sufficient to support NADPH-dependent activity of cobalamin-dependent methionine synthase. Condition category: normal nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The flavin reductase helps restore an enzyme that uses B12 and methylfolate. organism: Homo sapiens tissue_or_cell_type: Purified recombinant enzyme; no intact tissue experimental_model: Recombinant human MTRR purification, flavin analysis, NADPH spectroscopy and methionine-synthase reconstitution. limitations: Reconstituted biochemistry; the accessible abstract identifies human MTRR but not the target MTR species. No dietary B2/B12 synergy was tested. exposure: Purified-enzyme assay cross_nutrient: B2 flavins support reactivation of B12-dependent folate/homocysteine metabolism. evidence_location: Abstract [olteanu2001] Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. (2001). https://pubmed.ncbi.nlm.nih.gov/11466310/ DOI: 10.1074/jbc.m103707200
Complete structured claim and evidenceEngineered rat TXNRD1 terminal mutants retained one FAD per subunit and rapidly formed a thiolate-flavin charge-transfer signal upon NADPH titration.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Distinct B2-cofactor and selenium-site functions cannot substitute for one another.
- evidence_location
- Abstract
- experimental_model
- Rat TXNRD1 Sec498Cys, Sec498Ser and C-terminal truncation expressed in E. coli; FAD analysis, NADPH titration and thioredoxin assays.
- exposure
- Purified-enzyme assay
- limitations
- Includes Sec498Cys, Sec498Ser and terminal truncation; engineered proteins, not nutrient-depleted animals.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Rattus norvegicus protein expressed in Escherichia coli
- plain_language
- A defective terminal center can leave upstream flavin reduction intact.
- primary_references
- [zhong2000] Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. (2000). https://pubmed.ncbi.nlm.nih.gov/10849437/ DOI: 10.1074/jbc.m000690200
- tissue_or_cell_type
- Purified recombinant enzyme; no intact tissue
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1374–1386
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Rat TXNRD1 Sec498Cys, Sec498Ser and C-terminal truncation expressed in E. coli; FAD analysis, NADPH titration and thioredoxin assays. · source_derived_draft · unverified_draft
### b2-txnrd-mutants-upstream-retained Engineered rat TXNRD1 terminal mutants retained one FAD per subunit and rapidly formed a thiolate-flavin charge-transfer signal upon NADPH titration. Condition category: machinery_impairment nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A defective terminal center can leave upstream flavin reduction intact. organism: Rattus norvegicus protein expressed in Escherichia coli tissue_or_cell_type: Purified recombinant enzyme; no intact tissue experimental_model: Rat TXNRD1 Sec498Cys, Sec498Ser and C-terminal truncation expressed in E. coli; FAD analysis, NADPH titration and thioredoxin assays. limitations: Includes Sec498Cys, Sec498Ser and terminal truncation; engineered proteins, not nutrient-depleted animals. exposure: Purified-enzyme assay cross_nutrient: Distinct B2-cofactor and selenium-site functions cannot substitute for one another. evidence_location: Abstract [zhong2000] Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. (2000). https://pubmed.ncbi.nlm.nih.gov/10849437/ DOI: 10.1074/jbc.m000690200
Complete structured claim and evidenceRat liver microsomal induction/inhibition experiments implicated CYP2E1 as the major enzyme oxidizing indole to indoxyl with NADPH support.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat liver microsomes with inducer/inhibitor profiling.
- limitations
- CYP2E1 assignment is supported by convergent microsomal tests rather than exclusive purified-enzyme proof.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- A gut-derived indole can enter a liver oxidation route.
- primary_references
- Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11808865/ · DOI 10.1007/BF03226377
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 586–592
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat liver microsomes with inducer/inhibitor profiling. · source_derived_draft · unverified_draft
## tryptophan-indole-oxidation A gut-derived indole can enter a liver oxidation route. Rat liver microsomal induction/inhibition experiments implicated CYP2E1 as the major enzyme oxidizing indole to indoxyl with NADPH support. Model: Rat liver microsomes with inducer/inhibitor profiling. Limitations: CYP2E1 assignment is supported by convergent microsomal tests rather than exclusive purified-enzyme proof. Evidence access: Primary abstract Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11808865/ · DOI 10.1007/BF03226377
Complete structured claim and evidenceErythrocytes from a G6PD-deficient person failed to reduce lipoic acid in the assay; pharmacological G6PD inhibition also prevented reduction.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"}
- experimental_model
- Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays
- exposure
- Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition
- limitations
- The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human
- plain_language
- Providing the oxidized molecule did not overcome the missing reducing capacity.
- primary_references
- [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
- tissue_or_cell_type
- Erythrocytes and glutathione reductase
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 728–739
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays · source_derived_draft · unverified_draft
### ala-g6pd-reduction-failure Erythrocytes from a G6PD-deficient person failed to reduce lipoic acid in the assay; pharmacological G6PD inhibition also prevented reduction. Condition category: machinery_impairment nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Providing the oxidized molecule did not overcome the missing reducing capacity. organism: Human tissue_or_cell_type: Erythrocytes and glutathione reductase experimental_model: Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays limitations: The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency. exposure: Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition evidence_span: {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"} [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
Complete structured claim and evidencePurified human glutathione reductase reduced free lipoic acid to DHLA in vitro.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"}
- experimental_model
- Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays
- exposure
- Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition
- limitations
- The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human
- plain_language
- An enzyme associated with glutathione recycling can also reduce free lipoic acid.
- primary_references
- [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
- tissue_or_cell_type
- Erythrocytes and glutathione reductase
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 741–752
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays · source_derived_draft · unverified_draft
### ala-gsr-free-lipoate Purified human glutathione reductase reduced free lipoic acid to DHLA in vitro. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: An enzyme associated with glutathione recycling can also reduce free lipoic acid. organism: Human tissue_or_cell_type: Erythrocytes and glutathione reductase experimental_model: Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays limitations: The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency. exposure: Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition evidence_span: {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"} [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
Complete structured claim and evidenceHuman erythrocytes reduced lipoic acid to DHLA with glucose but not with 2-deoxyglucose, supporting NADPH dependence.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"}
- experimental_model
- Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays
- exposure
- Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition
- limitations
- The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human
- plain_language
- The cell must supply reducing power to make DHLA.
- primary_references
- [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
- tissue_or_cell_type
- Erythrocytes and glutathione reductase
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 715–726
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays · source_derived_draft · unverified_draft
### ala-rbc-glucose-reduction Human erythrocytes reduced lipoic acid to DHLA with glucose but not with 2-deoxyglucose, supporting NADPH dependence. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cell must supply reducing power to make DHLA. organism: Human tissue_or_cell_type: Erythrocytes and glutathione reductase experimental_model: Human erythrocytes, one G6PD-deficient donor and purified-enzyme assays limitations: The deficient-donor finding is small and mechanistic; it is not a clinical safety or efficacy trial in G6PD deficiency. exposure: Lipoic acid with glucose/2-deoxyglucose and G6PD inhibition evidence_span: {"source_cache": "artifacts/ala-research/7632170.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707", "start_char": 0, "end_char": 1863, "text_sha256": "2ebbc851e5279e646bc7c892645c931a3fd2993830c3f4405379839cbbd6e707"} [ala-p7632170] Reduction and transport of lipoic acid by human erythrocytes. (1995). https://pubmed.ncbi.nlm.nih.gov/7632170/ DOI: 10.1016/0006-2952(95)00084-d
Complete structured claim and evidencePurified mammalian thioredoxin reductases, including enzyme from human placenta, catalyzed NADPH-dependent lipoic-acid reduction.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/8769129.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9ba6524ef04fdc03c0a6d108325b8a96fe7ad0748be4d7056e694b5afa2a8499", "start_char": 0, "end_char": 1307, "text_sha256": "9ba6524ef04fdc03c0a6d108325b8a96fe7ad0748be4d7056e694b5afa2a8499"}
- experimental_model
- Purified mammalian thioredoxin reductase assays
- exposure
- NADPH-dependent lipoate/lipoamide reduction
- limitations
- Isoform identity was not resolved as a specific human TXNRD gene in the indexed abstract; assay rate comparisons are not tissue-wide flux rankings.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human placenta, calf tissues and rat liver
- plain_language
- The thioredoxin system provides another route to DHLA.
- primary_references
- [ala-p8769129] Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. (1996). https://pubmed.ncbi.nlm.nih.gov/8769129/ DOI: 10.1006/bbrc.1996.1165
- tissue_or_cell_type
- Purified thioredoxin reductases
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 754–765
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified mammalian thioredoxin reductase assays · source_derived_draft · unverified_draft
### ala-thioredoxin-reductase-dhla Purified mammalian thioredoxin reductases, including enzyme from human placenta, catalyzed NADPH-dependent lipoic-acid reduction. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The thioredoxin system provides another route to DHLA. organism: Human placenta, calf tissues and rat liver tissue_or_cell_type: Purified thioredoxin reductases experimental_model: Purified mammalian thioredoxin reductase assays limitations: Isoform identity was not resolved as a specific human TXNRD gene in the indexed abstract; assay rate comparisons are not tissue-wide flux rankings. exposure: NADPH-dependent lipoate/lipoamide reduction evidence_span: {"source_cache": "artifacts/ala-research/8769129.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9ba6524ef04fdc03c0a6d108325b8a96fe7ad0748be4d7056e694b5afa2a8499", "start_char": 0, "end_char": 1307, "text_sha256": "9ba6524ef04fdc03c0a6d108325b8a96fe7ad0748be4d7056e694b5afa2a8499"} [ala-p8769129] Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. (1996). https://pubmed.ncbi.nlm.nih.gov/8769129/ DOI: 10.1006/bbrc.1996.1165
Complete structured claim and evidenceA separate study found NADK2 loss depleted mitochondrial NADPH, limited P5C generation and made tested mammalian cells dependent on exogenous proline for growth.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mammalian NADK2-deletion cell models; primary abstract.
- limitations
- Detailed model and exposure differences remain distinct; the two publications are not duplicate evidence records from one experiment.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- A second research group found the same synthesis vulnerability.
- primary_references
- Mitochondrial NADP+ is essential for proline biosynthesis during cell growth. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33833463/ · DOI 10.1038/s42255-021-00374-y
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 78–84
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mammalian NADK2-deletion cell models; primary abstract. · source_derived_draft · unverified_draft
## l-proline-nadk2-independent-study A second research group found the same synthesis vulnerability. A separate study found NADK2 loss depleted mitochondrial NADPH, limited P5C generation and made tested mammalian cells dependent on exogenous proline for growth. Model: Mammalian NADK2-deletion cell models; primary abstract. Limitations: Detailed model and exposure differences remain distinct; the two publications are not duplicate evidence records from one experiment. Evidence access: Primary abstract Mitochondrial NADP+ is essential for proline biosynthesis during cell growth. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33833463/ · DOI 10.1038/s42255-021-00374-y
Complete structured claim and evidenceCRISPR deletion of NADK2 in human DLD1 cells reduced mitochondrial NADP(H) by more than 80% while whole-cell NADP(H) was not similarly depleted.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human DLD1 cells; immunopurified mitochondrial fractions and enzyme-cycling assays.
- limitations
- A compartment-specific genetic manipulation is not equivalent to dietary niacin deficiency.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- The cofactor pool inside mitochondria can fail even when a whole-cell measurement looks adequate.
- primary_references
- Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 54–60
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human DLD1 cells; immunopurified mitochondrial fractions and enzyme-cycling assays. · source_derived_draft · unverified_draft
## l-proline-nadk2-pool The cofactor pool inside mitochondria can fail even when a whole-cell measurement looks adequate. CRISPR deletion of NADK2 in human DLD1 cells reduced mitochondrial NADP(H) by more than 80% while whole-cell NADP(H) was not similarly depleted. Model: Human DLD1 cells; immunopurified mitochondrial fractions and enzyme-cycling assays. Limitations: A compartment-specific genetic manipulation is not equivalent to dietary niacin deficiency. Evidence access: Primary full text Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
Complete structured claim and evidenceNADK2 deletion reduced glutamine-derived proline synthesis; mitochondrial NADP(H) was needed for the P5CS step reducing glutamate toward P5C.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cell deletion, isotope tracing and rescue experiments.
- limitations
- The limiting step was cofactor-dependent synthesis, not a demonstrated lack of glutamine in the diet.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Proline production needs reducing power in the right compartment.
- primary_references
- Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 62–68
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cell deletion, isotope tracing and rescue experiments. · source_derived_draft · unverified_draft
## l-proline-nadk2-proline Proline production needs reducing power in the right compartment. NADK2 deletion reduced glutamine-derived proline synthesis; mitochondrial NADP(H) was needed for the P5CS step reducing glutamate toward P5C. Model: Human cell deletion, isotope tracing and rescue experiments. Limitations: The limiting step was cofactor-dependent synthesis, not a demonstrated lack of glutamine in the diet. Evidence access: Primary full text Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
Complete structured claim and evidenceUnder the tested culture conditions, NADK2 deletion did not increase measured mitochondrial oxidative stress or disrupt mitochondrial folate pathway activity despite reduced proline synthesis.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cell models; ROS probes, targeted redox sensors and serine isotope tracing.
- limitations
- The authors do not exclude effects during other physiological stresses; this is not a universal claim that mitochondrial NADPH is irrelevant to antioxidant defense.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Losing this cofactor pool did not shut down every pathway that might be connected to it.
- primary_references
- Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 86–92
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cell models; ROS probes, targeted redox sensors and serine isotope tracing. · source_derived_draft · unverified_draft
## l-proline-nadk2-redox-boundary Losing this cofactor pool did not shut down every pathway that might be connected to it. Under the tested culture conditions, NADK2 deletion did not increase measured mitochondrial oxidative stress or disrupt mitochondrial folate pathway activity despite reduced proline synthesis. Model: Human cell models; ROS probes, targeted redox sensors and serine isotope tracing. Limitations: The authors do not exclude effects during other physiological stresses; this is not a universal claim that mitochondrial NADPH is irrelevant to antioxidant defense. Evidence access: Primary full text Mitochondrial NADP(H) generation is essential for proline biosynthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33888598/ · DOI 10.1126/science.abd5491
Complete structured claim and evidenceRecombinant human PYCR1 reduced P5C to proline with NADH or NADPH; in the tested conditions its specific activity was higher with NADH.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified human enzyme; comparison with 0.1 mM P5C and 0.1 mM reduced cofactor, 37 degrees C.
- limitations
- Cofactor preference depends on assay conditions and does not make the alternative cofactor unusable.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- One mitochondrial enzyme finishes the synthesis of proline.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 14–20
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human enzyme; comparison with 0.1 mM P5C and 0.1 mM reduced cofactor, 37 degrees C. · source_derived_draft · unverified_draft
## l-proline-pycr1-reduction One mitochondrial enzyme finishes the synthesis of proline. Recombinant human PYCR1 reduced P5C to proline with NADH or NADPH; in the tested conditions its specific activity was higher with NADH. Model: Purified human enzyme; comparison with 0.1 mM P5C and 0.1 mM reduced cofactor, 37 degrees C. Limitations: Cofactor preference depends on assay conditions and does not make the alternative cofactor unusable. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidenceRecombinant human PYCR2 reduced P5C to proline and favored NADH over NADPH under the reported comparison conditions.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified human PYCR2 and human melanoma-cell localization experiments.
- limitations
- PYCR2 has its own identity and disease associations; it is not interchangeable with PYCR1.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- A second mitochondrial enzyme performs the final reduction.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 22–28
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human PYCR2 and human melanoma-cell localization experiments. · source_derived_draft · unverified_draft
## l-proline-pycr2-reduction A second mitochondrial enzyme performs the final reduction. Recombinant human PYCR2 reduced P5C to proline and favored NADH over NADPH under the reported comparison conditions. Model: Purified human PYCR2 and human melanoma-cell localization experiments. Limitations: PYCR2 has its own identity and disease associations; it is not interchangeable with PYCR1. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidenceHuman PYCRL/PYCR3 localized predominantly to the cytosol in the tested melanoma cells and was more efficient with NADPH in the biochemical comparison.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Lu1205 cell fractionation and recombinant human PYCRL kinetics.
- limitations
- The melanoma routing pattern is not asserted to apply identically in every human tissue.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- The cytosolic version has different preferences from the mitochondrial enzymes.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 30–36
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Lu1205 cell fractionation and recombinant human PYCRL kinetics. · source_derived_draft · unverified_draft
## l-proline-pycr3-reduction The cytosolic version has different preferences from the mitochondrial enzymes. Human PYCRL/PYCR3 localized predominantly to the cytosol in the tested melanoma cells and was more efficient with NADPH in the biochemical comparison. Model: Lu1205 cell fractionation and recombinant human PYCRL kinetics. Limitations: The melanoma routing pattern is not asserted to apply identically in every human tissue. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidenceTGF-beta induced glutamine-derived proline synthesis in a Smad4-dependent fibroblast program; manipulations of mitochondrial redox potential or ATP production changed that synthesis.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- TGF-beta-stimulated fibroblast experiments; primary abstract, with mouse NIH3T3 model identified in the primary study.
- limitations
- No dietary dose or general antifibrotic benefit is inferred.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Activated matrix-producing cells can use proline synthesis to handle metabolic demand.
- primary_references
- Proline biosynthesis is a vent for TGFβ-induced mitochondrial redox stress. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32134147/ · DOI 10.15252/embj.2019103334
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 366–372
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · TGF-beta-stimulated fibroblast experiments; primary abstract, with mouse NIH3T3 model identified in the primary study. · source_derived_draft · unverified_draft
## l-proline-tgfb-proline Activated matrix-producing cells can use proline synthesis to handle metabolic demand. TGF-beta induced glutamine-derived proline synthesis in a Smad4-dependent fibroblast program; manipulations of mitochondrial redox potential or ATP production changed that synthesis. Model: TGF-beta-stimulated fibroblast experiments; primary abstract, with mouse NIH3T3 model identified in the primary study. Limitations: No dietary dose or general antifibrotic benefit is inferred. Evidence access: Primary abstract Proline biosynthesis is a vent for TGFβ-induced mitochondrial redox stress. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32134147/ · DOI 10.15252/embj.2019103334
Complete structured claim and evidencePurified E. coli K12 azoreductase I used tartrazine as a substrate.
Experimental context and source evidence
- dose
- Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract
- duration
- Assay interval unavailable in primary abstract
- evidence_access
- Primary PubMed abstract; unrecovered method details explicitly retained.
- evidence_scope
- literature_reviewed; source-specific experimental curation
- experimental_model
- Purified Escherichia coli K12 azoreductases I and II
- limitations
- Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved.
- nutrient_topic
- Tartrazine food-colorant chapter; nutrient, drug and peptide interactions retain their models and limits. · Tartrazine
- organism
- Purified Escherichia coli K12 azoreductases I and II
- plain_language
- Purified E. coli K12 azoreductase I used tartrazine as a substrate.
- primary_references
- Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/
- route
- In vitro enzyme/substrate incubation
- tissue
- Cell-free azo-reduction assays
Tartrazine: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 17–26
Original AI-assisted curation of eighteen primary studies. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Purified Escherichia coli K12 azoreductases I and II · source_derived_draft · unverified_draft
## tartrazine-azoreductase-i Purified E. coli K12 azoreductase I used tartrazine as a substrate. Model/species: Purified Escherichia coli K12 azoreductases I and II Tissue: Cell-free azo-reduction assays Exposure: Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract Route: In vitro enzyme/substrate incubation Duration: Assay interval unavailable in primary abstract Limits: Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved. Primary reference: Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/ Access: Primary PubMed abstract; unrecovered method details explicitly retained.
Complete structured claim and evidencePurified E. coli K12 azoreductase II used tartrazine less efficiently than azoreductase I.
Experimental context and source evidence
- dose
- Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract
- duration
- Assay interval unavailable in primary abstract
- evidence_access
- Primary PubMed abstract; unrecovered method details explicitly retained.
- evidence_scope
- literature_reviewed; source-specific experimental curation
- experimental_model
- Purified Escherichia coli K12 azoreductases I and II
- limitations
- Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved.
- nutrient_topic
- Tartrazine food-colorant chapter; nutrient, drug and peptide interactions retain their models and limits. · Tartrazine
- organism
- Purified Escherichia coli K12 azoreductases I and II
- plain_language
- Purified E. coli K12 azoreductase II used tartrazine less efficiently than azoreductase I.
- primary_references
- Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/
- route
- In vitro enzyme/substrate incubation
- tissue
- Cell-free azo-reduction assays
Tartrazine: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 28–37
Original AI-assisted curation of eighteen primary studies. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Purified Escherichia coli K12 azoreductases I and II · source_derived_draft · unverified_draft
## tartrazine-azoreductase-ii Purified E. coli K12 azoreductase II used tartrazine less efficiently than azoreductase I. Model/species: Purified Escherichia coli K12 azoreductases I and II Tissue: Cell-free azo-reduction assays Exposure: Tartrazine among tested substrates; exact substrate/cofactor concentrations unavailable in abstract Route: In vitro enzyme/substrate incubation Duration: Assay interval unavailable in primary abstract Limits: Both NADH and NADPH served as electron donors in enzyme characterization. This does not prove that niacin intake controls dye metabolism in humans. Protein genes and tartrazine-specific kinetic constants are unresolved. Primary reference: Purification of two azoreductases from Escherichia coli K12. (1993). https://pubmed.ncbi.nlm.nih.gov/8112774/ Access: Primary PubMed abstract; unrecovered method details explicitly retained.
Complete structured claim and evidenceThe reported boron-binding order was NAD+ > NADH > NADP+ > NADPH at pH 10.3; only the NAD+ complex was observed in the separate pH 7.4 ammonium-bicarbonate condition.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/boron-research/15282753.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9385dca91d3dc7bb5a3d2a9c71a8e4c4ec0af136a15de2ea9536365a048d8057", "start_char": 0, "end_char": 1378, "text_sha256": "9385dca91d3dc7bb5a3d2a9c71a8e4c4ec0af136a15de2ea9536365a048d8057"}
- experimental_model
- Electrospray mass spectrometry comparing nucleotide binding
- exposure
- 100 µM nucleotide and 500 µM boric acid in WAT solvent at pH 10.3; separate pH 7.4 ammonium bicarbonate condition
- limitations
- Relative ion signals and assay-specific rankings cannot be treated as universal binding constants or in-vivo metabolic effects.
- nutrient_topic
- Boron research collection; topical membership is not evidence of a direct dietary effect. · Boron
- organism
- Cell-free chemistry
- plain_language
- Added phosphate groups and the test solution change the observed binding pattern.
- primary_references
- [boron-p15282753] Borate-nucleotide complex formation depends on charge and phosphorylation state. (2004). https://pubmed.ncbi.nlm.nih.gov/15282753/ DOI: 10.1002/jms.645
- tissue_or_cell_type
- Purified nucleotide solutions
Boron: chemistry, nutrient interactions, low-intake studies and mechanistic uncertainties (2026-09-17) · lines 144–155
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Electrospray mass spectrometry comparing nucleotide binding · source_derived_draft · unverified_draft
### boron-nad-phosphate-context The reported boron-binding order was NAD+ > NADH > NADP+ > NADPH at pH 10.3; only the NAD+ complex was observed in the separate pH 7.4 ammonium-bicarbonate condition. Condition category: normal nutrient_topic: Boron research collection; topical membership is not evidence of a direct dietary effect. plain_language: Added phosphate groups and the test solution change the observed binding pattern. organism: Cell-free chemistry tissue_or_cell_type: Purified nucleotide solutions experimental_model: Electrospray mass spectrometry comparing nucleotide binding limitations: Relative ion signals and assay-specific rankings cannot be treated as universal binding constants or in-vivo metabolic effects. exposure: 100 µM nucleotide and 500 µM boric acid in WAT solvent at pH 10.3; separate pH 7.4 ammonium bicarbonate condition evidence_span: {"source_cache": "artifacts/boron-research/15282753.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9385dca91d3dc7bb5a3d2a9c71a8e4c4ec0af136a15de2ea9536365a048d8057", "start_char": 0, "end_char": 1378, "text_sha256": "9385dca91d3dc7bb5a3d2a9c71a8e4c4ec0af136a15de2ea9536365a048d8057"} [boron-p15282753] Borate-nucleotide complex formation depends on charge and phosphorylation state. (2004). https://pubmed.ncbi.nlm.nih.gov/15282753/ DOI: 10.1002/jms.645
Complete structured claim and evidenceHuman MMACHC converted bound cyanocobalamin to cob(II)alamin during NADPH-supported reductive decyanation; EPR identified the product in a base-off coordination state.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Results: Figure 4; Materials and Methods: Decyanation of CNCbl
- experimental_model
- Purified human MMACHC with human flavoprotein donor
- exposure
- Anaerobic CNCbl/MMACHC, NADPH and MTRR or NDOR1
- limitations
- Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- Processing removes the cyano group and leaves a reduced B12 intermediate.
- primary_references
- [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
- tissue_or_cell_type
- Cell-free assay
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 669–681
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human MMACHC with human flavoprotein donor · source_derived_draft · unverified_draft
### b12-mmachc-decyanation Human MMACHC converted bound cyanocobalamin to cob(II)alamin during NADPH-supported reductive decyanation; EPR identified the product in a base-off coordination state. Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: Processing removes the cyano group and leaves a reduced B12 intermediate. organism: Homo sapiens tissue_or_cell_type: Cell-free assay experimental_model: Purified human MMACHC with human flavoprotein donor limitations: Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans. exposure: Anaerobic CNCbl/MMACHC, NADPH and MTRR or NDOR1 cross_nutrient: true evidence_location: Results: Figure 4; Materials and Methods: Decyanation of CNCbl [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
Complete structured claim and evidenceHuman MMACHC residues 1–244 supported cyanocobalamin decyanation with FMN or FAD plus NADPH, without a separately supplied flavoprotein reductase; reduced FMN also supported the reaction.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- true
- evidence_location
- Experimental procedures and Results: CblC Has a Flavin Reductase Fold; Figure 1c
- experimental_model
- Recombinant human MMACHC deltaC38 biochemical assay
- exposure
- 30–40 micromolar FMN/FAD with 200 micromolar NADPH, or photoreduced FMN
- limitations
- Engineered truncation and reconstitution; does not establish that riboflavin supplementation rescues MMACHC defects.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- A truncated B12-processing protein could use supplied flavins to carry out this reaction.
- primary_references
- [koutmos-2011-flavin] Structural Basis of Multifunctionality in a Vitamin B12-processing Enzyme (2011). https://pubmed.ncbi.nlm.nih.gov/21697092/ DOI: 10.1074/jbc.M111.261370
- tissue_or_cell_type
- Cell-free assay
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 753–765
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human MMACHC deltaC38 biochemical assay · source_derived_draft · unverified_draft
### b12-mmachc-free-flavin-decyanation Human MMACHC residues 1–244 supported cyanocobalamin decyanation with FMN or FAD plus NADPH, without a separately supplied flavoprotein reductase; reduced FMN also supported the reaction. Condition category: machinery_impairment nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A truncated B12-processing protein could use supplied flavins to carry out this reaction. organism: Homo sapiens tissue_or_cell_type: Cell-free assay experimental_model: Recombinant human MMACHC deltaC38 biochemical assay limitations: Engineered truncation and reconstitution; does not establish that riboflavin supplementation rescues MMACHC defects. exposure: 30–40 micromolar FMN/FAD with 200 micromolar NADPH, or photoreduced FMN cross_nutrient: true evidence_location: Experimental procedures and Results: CblC Has a Flavin Reductase Fold; Figure 1c [koutmos-2011-flavin] Structural Basis of Multifunctionality in a Vitamin B12-processing Enzyme (2011). https://pubmed.ncbi.nlm.nih.gov/21697092/ DOI: 10.1074/jbc.M111.261370
Complete structured claim and evidenceRecombinant human MTRR with NADPH supported MMACHC-bound cyanocobalamin conversion to cob(II)alamin; free cyanocobalamin was not detectably reduced without MMACHC.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Results: Figure 4; Materials and Methods: Decyanation of CNCbl
- experimental_model
- Human purified-protein anaerobic reconstitution
- exposure
- 4 micromolar reductase, 20 micromolar MMACHC/CNCbl, 200 micromolar NADPH
- limitations
- Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- This flavoprotein can pass reducing power into B12 processing.
- primary_references
- [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
- tissue_or_cell_type
- Cell-free assay
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 683–695
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human purified-protein anaerobic reconstitution · source_derived_draft · unverified_draft
### b12-mtrr-mmachc-electrons Recombinant human MTRR with NADPH supported MMACHC-bound cyanocobalamin conversion to cob(II)alamin; free cyanocobalamin was not detectably reduced without MMACHC. Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This flavoprotein can pass reducing power into B12 processing. organism: Homo sapiens tissue_or_cell_type: Cell-free assay experimental_model: Human purified-protein anaerobic reconstitution limitations: Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans. exposure: 4 micromolar reductase, 20 micromolar MMACHC/CNCbl, 200 micromolar NADPH cross_nutrient: true evidence_location: Results: Figure 4; Materials and Methods: Decyanation of CNCbl [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
Complete structured claim and evidenceRecombinant human NDOR1/NR1 with NADPH supported MMACHC-bound cyanocobalamin conversion to cob(II)alamin; free cyanocobalamin was not detectably reduced without MMACHC.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Results: Figure 4; Materials and Methods: Decyanation of CNCbl
- experimental_model
- Human purified-protein anaerobic reconstitution
- exposure
- 4 micromolar reductase, 20 micromolar MMACHC/CNCbl, 200 micromolar NADPH
- limitations
- Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- This flavoprotein can pass reducing power into B12 processing.
- primary_references
- [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
- tissue_or_cell_type
- Cell-free assay
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 697–709
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human purified-protein anaerobic reconstitution · source_derived_draft · unverified_draft
### b12-ndor1-mmachc-electrons Recombinant human NDOR1/NR1 with NADPH supported MMACHC-bound cyanocobalamin conversion to cob(II)alamin; free cyanocobalamin was not detectably reduced without MMACHC. Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This flavoprotein can pass reducing power into B12 processing. organism: Homo sapiens tissue_or_cell_type: Cell-free assay experimental_model: Human purified-protein anaerobic reconstitution limitations: Reconstituted biochemical system; establishes reaction capability rather than the quantitatively dominant pathway in living humans. exposure: 4 micromolar reductase, 20 micromolar MMACHC/CNCbl, 200 micromolar NADPH cross_nutrient: true evidence_location: Results: Figure 4; Materials and Methods: Decyanation of CNCbl [kim-2008-decyanation] Decyanation of vitamin B12 by a trafficking chaperone (2008). https://pubmed.ncbi.nlm.nih.gov/18779575/ DOI: 10.1073/pnas.0805989105
Complete structured claim and evidenceHuman [2Fe-2S] ferredoxin FDX1 supplied electrons for MMAB-dependent adenosylcobalamin synthesis in the FDXR/NADPH reconstitution.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Abstract and indexed primary Results, Figure 3
- experimental_model
- Purified human proteins
- exposure
- FDX1, FDXR and NADPH with MMAB, cob(II)alamin and ATP
- limitations
- Biochemically competent donor; exclusivity or necessity in living humans was not tested.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- In the purified human system, an iron-sulfur electron carrier supported B12 activation.
- primary_references
- [gouda-2023-mmab-redox] Coordination Chemistry Controls Coenzyme B12 Synthesis by Human Adenosine Triphosphate:Cob(I)alamin Adenosyltransferase. (2023). https://pubmed.ncbi.nlm.nih.gov/37526260/ DOI: 10.1021/acs.inorgchem.3c02163
- tissue_or_cell_type
- Purified protein assay
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1005–1017
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human proteins · source_derived_draft · unverified_draft
### fdx1-supports-mmab Human [2Fe-2S] ferredoxin FDX1 supplied electrons for MMAB-dependent adenosylcobalamin synthesis in the FDXR/NADPH reconstitution. Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: In the purified human system, an iron-sulfur electron carrier supported B12 activation. organism: Homo sapiens tissue_or_cell_type: Purified protein assay experimental_model: Purified human proteins limitations: Biochemically competent donor; exclusivity or necessity in living humans was not tested. exposure: FDX1, FDXR and NADPH with MMAB, cob(II)alamin and ATP cross_nutrient: true evidence_location: Abstract and indexed primary Results, Figure 3 [gouda-2023-mmab-redox] Coordination Chemistry Controls Coenzyme B12 Synthesis by Human Adenosine Triphosphate:Cob(I)alamin Adenosyltransferase. (2023). https://pubmed.ncbi.nlm.nih.gov/37526260/ DOI: 10.1021/acs.inorgchem.3c02163
Complete structured claim and evidenceR186Q human MMAB showed no detectable adenosylcobalamin synthesis with FDX1/FDXR/NADPH, although a strong chemical reductant supported activity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- true
- evidence_location
- Abstract and indexed primary Results, Figure 3
- experimental_model
- Purified human MMAB R186Q
- exposure
- R186Q variant; FDX1/FDXR/NADPH versus titanium(III)citrate
- limitations
- Detection-limited in-vitro activity; not proof of zero activity in every tissue.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- This MMAB variant failed in the ferredoxin assay; the result depended on the electron donor.
- primary_references
- [gouda-2023-mmab-redox] Coordination Chemistry Controls Coenzyme B12 Synthesis by Human Adenosine Triphosphate:Cob(I)alamin Adenosyltransferase. (2023). https://pubmed.ncbi.nlm.nih.gov/37526260/ DOI: 10.1021/acs.inorgchem.3c02163
- tissue_or_cell_type
- Purified protein assay
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1019–1031
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human MMAB R186Q · source_derived_draft · unverified_draft
### mmab-r186q-fdx-system-fails R186Q human MMAB showed no detectable adenosylcobalamin synthesis with FDX1/FDXR/NADPH, although a strong chemical reductant supported activity. Condition category: machinery_impairment nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This MMAB variant failed in the ferredoxin assay; the result depended on the electron donor. organism: Homo sapiens tissue_or_cell_type: Purified protein assay experimental_model: Purified human MMAB R186Q limitations: Detection-limited in-vitro activity; not proof of zero activity in every tissue. exposure: R186Q variant; FDX1/FDXR/NADPH versus titanium(III)citrate cross_nutrient: true evidence_location: Abstract and indexed primary Results, Figure 3 [gouda-2023-mmab-redox] Coordination Chemistry Controls Coenzyme B12 Synthesis by Human Adenosine Triphosphate:Cob(I)alamin Adenosyltransferase. (2023). https://pubmed.ncbi.nlm.nih.gov/37526260/ DOI: 10.1021/acs.inorgchem.3c02163
Complete structured claim and evidencePurified human MTRR coupled cob(II)alamin reduction to MMAB-dependent adenosylcobalamin synthesis in vitro.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Indexed primary abstract
- experimental_model
- Purified human proteins
- exposure
- Purified MTRR plus MMAB and reductants
- limitations
- MTRR coupling in vitro does not identify the physiological mitochondrial electron donor.
- nutrient_topic
- Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
- organism
- Homo sapiens
- plain_language
- Human MTRR supported B12 activation in a test-tube system; this does not establish its mitochondrial role.
- primary_references
- [leal-2004-human-mmab] Human ATP:Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase. (2004). https://pubmed.ncbi.nlm.nih.gov/15347655/ DOI: 10.1074/jbc.m405449200
- tissue_or_cell_type
- Purified protein assay
Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 991–1003
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human proteins · source_derived_draft · unverified_draft
### mtrr-supports-mmab-in-vitro Purified human MTRR coupled cob(II)alamin reduction to MMAB-dependent adenosylcobalamin synthesis in vitro. Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: Human MTRR supported B12 activation in a test-tube system; this does not establish its mitochondrial role. organism: Homo sapiens tissue_or_cell_type: Purified protein assay experimental_model: Purified human proteins limitations: MTRR coupling in vitro does not identify the physiological mitochondrial electron donor. exposure: Purified MTRR plus MMAB and reductants cross_nutrient: true evidence_location: Indexed primary abstract [leal-2004-human-mmab] Human ATP:Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase. (2004). https://pubmed.ncbi.nlm.nih.gov/15347655/ DOI: 10.1074/jbc.m405449200
Complete structured claim and evidenceMyricetin inhibition was time- and NADPH-dependent and involved the reduced C-terminal Cys-Sec-Gly active site.
Experimental context and source evidence
- evidence_access
- Primary abstract and publisher methods/results
- experimental_model
- Rat TrxR biochemical experiments.
- limitations
- Semiquinone mediation was proposed; do not treat the precise intermediate as directly proven.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- The enzyme’s chemical state affects vulnerability.
- primary_references
- Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16618767/ · DOI 10.1158/0008-5472.CAN-05-3310
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 260–266
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat TrxR biochemical experiments. · source_derived_draft · unverified_draft
## myricetin-txnrd-active-site The enzyme’s chemical state affects vulnerability. Myricetin inhibition was time- and NADPH-dependent and involved the reduced C-terminal Cys-Sec-Gly active site. Model: Rat TrxR biochemical experiments. Limitations: Semiquinone mediation was proposed; do not treat the precise intermediate as directly proven. Evidence access: Primary abstract and publisher methods/results Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16618767/ · DOI 10.1158/0008-5472.CAN-05-3310
Complete structured claim and evidenceMyricetin inhibited NADPH-reduced recombinant rat TrxR1, IC50 0.62 micromolar after the reported preincubation.
Experimental context and source evidence
- evidence_access
- Primary abstract and publisher methods/results
- experimental_model
- Recombinant rat TrxR; one-hour preincubation and DTNB assay.
- limitations
- Enzyme potency differs from cellular exposure; not human dietary selenium depletion.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- A selenium-containing defense enzyme can be inhibited.
- primary_references
- Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16618767/ · DOI 10.1158/0008-5472.CAN-05-3310
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 252–258
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant rat TrxR; one-hour preincubation and DTNB assay. · source_derived_draft · unverified_draft
## myricetin-txnrd-inhibition A selenium-containing defense enzyme can be inhibited. Myricetin inhibited NADPH-reduced recombinant rat TrxR1, IC50 0.62 micromolar after the reported preincubation. Model: Recombinant rat TrxR; one-hour preincubation and DTNB assay. Limitations: Enzyme potency differs from cellular exposure; not human dietary selenium depletion. Evidence access: Primary abstract and publisher methods/results Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. · 2006 · https://pubmed.ncbi.nlm.nih.gov/16618767/ · DOI 10.1158/0008-5472.CAN-05-3310
Complete structured claim and evidenceHigh SLC7A11-mediated cystine uptake increased reliance on glucose and the pentose phosphate pathway; glucose deprivation depleted NADPH and promoted intracellular disulfide accumulation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays.
- limitations
- Complete glucose withdrawal in culture is not ordinary fasting or dietary carbohydrate restriction.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Importing more oxidized nutrient also creates more work for the reducing system.
- primary_references
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 236–242
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays. · source_derived_draft · unverified_draft
## l-cysteine-cystine-nadph-demand Importing more oxidized nutrient also creates more work for the reducing system. High SLC7A11-mediated cystine uptake increased reliance on glucose and the pentose phosphate pathway; glucose deprivation depleted NADPH and promoted intracellular disulfide accumulation. Model: Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays. Limitations: Complete glucose withdrawal in culture is not ordinary fasting or dietary carbohydrate restriction. Evidence access: Primary full text Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
Complete structured claim and evidencePreventing cystine uptake or removing cystine relieved the disulfide stress associated with glucose deprivation in SLC7A11-high cells.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cancer-cell glucose/cystine manipulation.
- limitations
- This is distinct from cystine-withdrawal ferroptosis under other conditions; no universal benefit of removing cystine is implied.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Reducing the incoming load helped when the cell could not process it.
- primary_references
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 244–250
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell glucose/cystine manipulation. · source_derived_draft · unverified_draft
## l-cysteine-cystine-reduction-rescue Reducing the incoming load helped when the cell could not process it. Preventing cystine uptake or removing cystine relieved the disulfide stress associated with glucose deprivation in SLC7A11-high cells. Model: Human cancer-cell glucose/cystine manipulation. Limitations: This is distinct from cystine-withdrawal ferroptosis under other conditions; no universal benefit of removing cystine is implied. Evidence access: Primary full text Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
Complete structured claim and evidenceGlucose starvation of SLC7A11-high human cancer cells induced abnormal disulfide bonding in actin-cytoskeleton proteins, F-actin collapse and disulfidptosis, distinct from apoptosis and ferroptosis.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract and primary publisher figure descriptions
- experimental_model
- Human cancer cultures, chemical proteomics and cell-biological assays.
- limitations
- Experimental deprivation; do not infer this occurs whenever blood glucose falls modestly.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The damage involved cross-linked structural proteins rather than the same lipid-peroxide pathway.
- primary_references
- Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36747082/ · DOI 10.1038/s41556-023-01091-2
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 252–258
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer cultures, chemical proteomics and cell-biological assays. · source_derived_draft · unverified_draft
## l-cysteine-disulfidptosis-actin The damage involved cross-linked structural proteins rather than the same lipid-peroxide pathway. Glucose starvation of SLC7A11-high human cancer cells induced abnormal disulfide bonding in actin-cytoskeleton proteins, F-actin collapse and disulfidptosis, distinct from apoptosis and ferroptosis. Model: Human cancer cultures, chemical proteomics and cell-biological assays. Limitations: Experimental deprivation; do not infer this occurs whenever blood glucose falls modestly. Evidence access: Primary abstract and primary publisher figure descriptions Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36747082/ · DOI 10.1038/s41556-023-01091-2
Complete structured claim and evidenceTRP14 removed cysteinyl mixed-disulfide modifications from human peroxiredoxin 2 and restored its peroxide-reducing activity in vitro.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Recombinant human Prx2; cysteinylation and hydrogen-peroxide reduction assays.
- limitations
- TRP14 repairs this modification; it is not being assigned the ordinary catalytic peroxide-reduction cycle of thioredoxin.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- A cysteine modification can temporarily obstruct another antioxidant enzyme.
- primary_references
- TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 84–90
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human Prx2; cysteinylation and hydrogen-peroxide reduction assays. · source_derived_draft · unverified_draft
## l-cysteine-protein-decysteinylation A cysteine modification can temporarily obstruct another antioxidant enzyme. TRP14 removed cysteinyl mixed-disulfide modifications from human peroxiredoxin 2 and restored its peroxide-reducing activity in vitro. Model: Recombinant human Prx2; cysteinylation and hydrogen-peroxide reduction assays. Limitations: TRP14 repairs this modification; it is not being assigned the ordinary catalytic peroxide-reduction cycle of thioredoxin. Evidence access: Primary full text TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
Complete structured claim and evidenceTXNDC17 knockout in human HEK293 cells markedly reduced intracellular cystine reduction; wild-type TRP14 re-expression restored activity whereas its active-site mutant did not.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human HEK293 knockout/rescue; fluorescent cystine-reduction assays.
- limitations
- The paper identifies a major rate-limiting route in tested systems, not the only possible reductase in every tissue.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Importing oxidized cysteine is not enough: the cell must reduce it to use it.
- primary_references
- TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 60–66
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HEK293 knockout/rescue; fluorescent cystine-reduction assays. · source_derived_draft · unverified_draft
## l-cysteine-trp14-cystine-reduction Importing oxidized cysteine is not enough: the cell must reduce it to use it. TXNDC17 knockout in human HEK293 cells markedly reduced intracellular cystine reduction; wild-type TRP14 re-expression restored activity whereas its active-site mutant did not. Model: Human HEK293 knockout/rescue; fluorescent cystine-reduction assays. Limitations: The paper identifies a major rate-limiting route in tested systems, not the only possible reductase in every tissue. Evidence access: Primary full text TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
Complete structured claim and evidenceThe reconstituted TRP14 system used thioredoxin reductase 1 and NADPH to drive disulfide-reduction reactions.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified enzyme systems, including human peroxiredoxin-2 decysteinylation.
- limitations
- This establishes a biochemical dependency; selenium or niacin depletion/repletion was not tested in this study.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The sulfur-supply step depends on an electron supply and another enzyme.
- primary_references
- TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 68–74
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified enzyme systems, including human peroxiredoxin-2 decysteinylation. · source_derived_draft · unverified_draft
## l-cysteine-trp14-electron-supply The sulfur-supply step depends on an electron supply and another enzyme. The reconstituted TRP14 system used thioredoxin reductase 1 and NADPH to drive disulfide-reduction reactions. Model: Purified enzyme systems, including human peroxiredoxin-2 decysteinylation. Limitations: This establishes a biochemical dependency; selenium or niacin depletion/repletion was not tested in this study. Evidence access: Primary full text TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
Complete structured claim and evidenceHuman P5CS links glutamate to P5C synthesis through ATP- and NADPH-dependent chemistry.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"}
- experimental_model
- Patient genetics and recombinant variant expression
- exposure
- ALDH18A1 R84Q compared with wild-type isoforms
- limitations
- Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, two siblings and mammalian expression systems
- plain_language
- This supplies a precursor route connected to ornithine and arginine production.
- primary_references
- [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
- tissue_or_cell_type
- Mitochondrial P5CS and circulating amino acids
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 294–305
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient genetics and recombinant variant expression · source_derived_draft · unverified_draft
### citrulline-p5cs-reaction Human P5CS links glutamate to P5C synthesis through ATP- and NADPH-dependent chemistry. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: This supplies a precursor route connected to ornithine and arginine production. organism: Human, two siblings and mammalian expression systems tissue_or_cell_type: Mitochondrial P5CS and circulating amino acids experimental_model: Patient genetics and recombinant variant expression limitations: Rare inherited enzyme disorder; does not imply low dietary citrulline caused the clinical phenotype. exposure: ALDH18A1 R84Q compared with wild-type isoforms evidence_span: {"source_cache": "artifacts/citrulline-research/11092761.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2", "start_char": 0, "end_char": 1688, "text_sha256": "09706fd9ec135c472473decaa612e06b3e5aa021c9b1493d77daf4fe98b8d5d2"} [citrulline-p11092761] Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. (2000). https://pubmed.ncbi.nlm.nih.gov/11092761/ DOI: 10.1093/hmg/9.19.2853
Complete structured claim and evidenceThe tested NADH kinase activity of purified human NADK2 Δ62 was about 10% of its NAD+ kinase activity.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nadk2-2012.fulltext.txt", "locator": "Results", "start_char": 9582, "end_char": 11594, "file_sha256": "65209c0b4ea7220bc95afdd182e40910f2445345172956e85552d5c6db649648", "text_sha256": "ffd25dd072f6f8f486b11ca632f28acf37e3ef2b0dbd2b20eecf32fce649eaf1"}
- experimental_model
- Purified NADK2 Δ62
- exposure
- ATP-dependent NADH versus NAD+ assays
- limitations
- Relative activity under the reported substrate conditions; not a universal cellular flux ratio.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Homo sapiens
- plain_language
- NADK2 could phosphorylate NADH in this assay, but favored NAD+.
- primary_references
- [nadk2-2012] Identification and characterization of a human mitochondrial NAD kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/23212377/ DOI: 10.1038/ncomms2262
- tissue_or_cell_type
- Purified enzyme
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 899–910
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified NADK2 Δ62 · source_derived_draft · unverified_draft
### b3-redox-nadk2-nadh-preference The tested NADH kinase activity of purified human NADK2 Δ62 was about 10% of its NAD+ kinase activity. Condition category: normal nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: NADK2 could phosphorylate NADH in this assay, but favored NAD+. organism: Homo sapiens tissue_or_cell_type: Purified enzyme experimental_model: Purified NADK2 Δ62 limitations: Relative activity under the reported substrate conditions; not a universal cellular flux ratio. exposure: ATP-dependent NADH versus NAD+ assays evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nadk2-2012.fulltext.txt", "locator": "Results", "start_char": 9582, "end_char": 11594, "file_sha256": "65209c0b4ea7220bc95afdd182e40910f2445345172956e85552d5c6db649648", "text_sha256": "ffd25dd072f6f8f486b11ca632f28acf37e3ef2b0dbd2b20eecf32fce649eaf1"} [nadk2-2012] Identification and characterization of a human mitochondrial NAD kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/23212377/ DOI: 10.1038/ncomms2262
Complete structured claim and evidenceDienoyl-CoA reductase activity was deficient in lysates from the NADK2 patient fibroblasts.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, enzyme assay", "start_char": 706, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "3e8d0b720e24732ab8f9603138f761f1dc2974876c1f81919cf5ecdae2f71eeb"}
- experimental_model
- Patient fibroblast lysate enzyme assay
- exposure
- Inherited NADK2 alteration
- limitations
- Abstract-backed genetic association plus rescue experiment; not proof that niacin supplementation restores enzyme activity.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Homo sapiens
- plain_language
- The impaired cofactor machinery was accompanied by loss of a dependent fatty-acid enzyme activity.
- primary_references
- [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
- tissue_or_cell_type
- Fibroblasts
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 977–988
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient fibroblast lysate enzyme assay · source_derived_draft · unverified_draft
### b3-redox-nadk2-patient-decr Dienoyl-CoA reductase activity was deficient in lysates from the NADK2 patient fibroblasts. Condition category: machinery_impairment nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The impaired cofactor machinery was accompanied by loss of a dependent fatty-acid enzyme activity. organism: Homo sapiens tissue_or_cell_type: Fibroblasts experimental_model: Patient fibroblast lysate enzyme assay limitations: Abstract-backed genetic association plus rescue experiment; not proof that niacin supplementation restores enzyme activity. exposure: Inherited NADK2 alteration evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, enzyme assay", "start_char": 706, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "3e8d0b720e24732ab8f9603138f761f1dc2974876c1f81919cf5ecdae2f71eeb"} [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
Complete structured claim and evidenceTransfection with functional NADK2 rescued deficient DECR activity in the patient-cell experiments.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, rescue experiment", "start_char": 706, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "3e8d0b720e24732ab8f9603138f761f1dc2974876c1f81919cf5ecdae2f71eeb"}
- experimental_model
- Functional NADK2 transfection of patient fibroblasts
- exposure
- Genetic complementation
- limitations
- Cellular gene rescue; neither dietary niacin nor NADPH dosing was shown to reproduce it.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Homo sapiens
- plain_language
- Replacing the defective kinase restored the enzyme readout in cells.
- primary_references
- [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
- tissue_or_cell_type
- Fibroblasts
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 990–1001
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Functional NADK2 transfection of patient fibroblasts · source_derived_draft · unverified_draft
### b3-redox-nadk2-patient-decr-rescue Transfection with functional NADK2 rescued deficient DECR activity in the patient-cell experiments. Condition category: machinery_impairment nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Replacing the defective kinase restored the enzyme readout in cells. organism: Homo sapiens tissue_or_cell_type: Fibroblasts experimental_model: Functional NADK2 transfection of patient fibroblasts limitations: Cellular gene rescue; neither dietary niacin nor NADPH dosing was shown to reproduce it. exposure: Genetic complementation evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, rescue experiment", "start_char": 706, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "3e8d0b720e24732ab8f9603138f761f1dc2974876c1f81919cf5ecdae2f71eeb"} [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
Complete structured claim and evidencePatient fibroblasts bearing a pathogenic NADK2 alteration had reduced mitochondrial NADP(H).
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, genetic and fibroblast results", "start_char": 357, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "e468b1beee1be208d337cdf94488aca05296b2dd3fcbba587ca323b8db6d2c96"}
- experimental_model
- Patient-derived fibroblasts
- exposure
- Inherited NADK2 alteration
- limitations
- Single described patient context; mitochondrial NADP(H) shortage arose from kinase machinery impairment, not demonstrated dietary niacin shortage.
- nutrient_topic
- Niacin research collection; topical membership is not evidence of a direct dietary effect. · Niacin (vitamin B3)
- organism
- Homo sapiens
- plain_language
- The genetic defect impaired the mitochondrial phosphorylated cofactor pool.
- primary_references
- [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
- tissue_or_cell_type
- Fibroblasts
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17) · lines 964–975
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient-derived fibroblasts · source_derived_draft · unverified_draft
### b3-redox-nadk2-patient-pool Patient fibroblasts bearing a pathogenic NADK2 alteration had reduced mitochondrial NADP(H). Condition category: machinery_impairment nutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The genetic defect impaired the mitochondrial phosphorylated cofactor pool. organism: Homo sapiens tissue_or_cell_type: Fibroblasts experimental_model: Patient-derived fibroblasts limitations: Single described patient context; mitochondrial NADP(H) shortage arose from kinase machinery impairment, not demonstrated dietary niacin shortage. exposure: Inherited NADK2 alteration evidence_span: {"source_cache": "artifacts/niacin-redox-sources/nadk2-patient-2014.abstract.txt", "locator": "Indexed abstract, genetic and fibroblast results", "start_char": 357, "end_char": 1462, "file_sha256": "0e8ce719f0454f41ce98a5c35f75c88a21f5219f0d9b574cf8a793697f39db5a", "text_sha256": "e468b1beee1be208d337cdf94488aca05296b2dd3fcbba587ca323b8db6d2c96"} [nadk2-patient-2014] Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (2014). https://pubmed.ncbi.nlm.nih.gov/24847004/ DOI: 10.1093/hmg/ddu218
Complete structured claim and evidenceThe AASS reductase domain condenses lysine with 2-oxoglutarate using NADPH to form saccharopine.
Experimental context and source evidence
- experimental_model
- Recombinant human AASS and isolated reductase domain
- limitations
- Reaction reversibility in vitro does not imply appreciable human lysine biosynthesis.
- organism
- Homo sapiens
- plain_language
- AASS starts the main lysine breakdown route.
- primary_references
- [leandro2022] Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1 (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9490328/ DOI: 10.1098/rsob.220179
- tissue_or_cell_type
- Mitochondrial matrix
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 74–82
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human AASS and isolated reductase domain · source_derived_draft · unverified_draft
### aass-reductase The AASS reductase domain condenses lysine with 2-oxoglutarate using NADPH to form saccharopine. Plain language: AASS starts the main lysine breakdown route. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Mitochondrial matrix experimental_model: Recombinant human AASS and isolated reductase domain limitations: Reaction reversibility in vitro does not imply appreciable human lysine biosynthesis. [leandro2022] Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1 (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9490328/ DOI: 10.1098/rsob.220179
Complete structured claim and evidenceCRYM ketimine reductase reduces P2C to L-pipecolate using reduced nicotinamide cofactors.
Experimental context and source evidence
- experimental_model
- Recombinant human CRYM and mammalian enzyme substrate assays
- limitations
- Catalytic capacity does not determine the route's quantitative contribution to human brain lysine clearance.
- organism
- Homo sapiens enzyme; ovine enzyme used for initial purification
- plain_language
- A ring-shaped intermediate can be reduced to pipecolate.
- primary_references
- [hallen2011] Mammalian forebrain ketimine reductase identified as mu-crystallin; potential regulation by thyroid hormones. (2011). https://pubmed.ncbi.nlm.nih.gov/21332720/ DOI: 10.1111/j.1471-4159.2011.07220.x [hallen2015] Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/mu-Crystallin Under Physiological Conditions. (2015). https://pubmed.ncbi.nlm.nih.gov/25931162/ DOI: 10.1007/s11064-015-1590-5
- tissue_or_cell_type
- Cytosolic enzyme; forebrain biochemical context
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 336–345
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human CRYM and mammalian enzyme substrate assays · source_derived_draft · unverified_draft
### crym-p2c-reduction CRYM ketimine reductase reduces P2C to L-pipecolate using reduced nicotinamide cofactors. Plain language: A ring-shaped intermediate can be reduced to pipecolate. Condition category: normal organism: Homo sapiens enzyme; ovine enzyme used for initial purification tissue_or_cell_type: Cytosolic enzyme; forebrain biochemical context experimental_model: Recombinant human CRYM and mammalian enzyme substrate assays limitations: Catalytic capacity does not determine the route's quantitative contribution to human brain lysine clearance. [hallen2011] Mammalian forebrain ketimine reductase identified as mu-crystallin; potential regulation by thyroid hormones. (2011). https://pubmed.ncbi.nlm.nih.gov/21332720/ DOI: 10.1111/j.1471-4159.2011.07220.x [hallen2015] Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/mu-Crystallin Under Physiological Conditions. (2015). https://pubmed.ncbi.nlm.nih.gov/25931162/ DOI: 10.1007/s11064-015-1590-5
Complete structured claim and evidenceDuring DHA reduction by human erythrocytes, 5 mM D-glucose maintained GSH and NADH concentrations whereas NADPH still declined; without glucose all three fell.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Human volunteer erythrocytes ex vivo
- exposure
- DHA challenge with or without 5 mM glucose
- limitations
- Metabolic support and transporter competition are different processes; this does not imply dietary sugar supplementation is needed.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Homo sapiens
- plain_language
- Glucose metabolism helped sustain the reducing resources used to recycle vitamin C.
- primary_references
- [may2001] Mechanisms of ascorbic acid recycling in human erythrocytes. (2001). https://pubmed.ncbi.nlm.nih.gov/11687303/ DOI: 10.1016/s0304-4165(01)00188-x
- tissue_or_cell_type
- Erythrocytes
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 325–336
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human volunteer erythrocytes ex vivo · source_derived_draft · unverified_draft
### vc-transport-rbc-glucose-support During DHA reduction by human erythrocytes, 5 mM D-glucose maintained GSH and NADH concentrations whereas NADPH still declined; without glucose all three fell. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glucose metabolism helped sustain the reducing resources used to recycle vitamin C. organism: Homo sapiens tissue_or_cell_type: Erythrocytes experimental_model: Human volunteer erythrocytes ex vivo limitations: Metabolic support and transporter competition are different processes; this does not imply dietary sugar supplementation is needed. exposure: DHA challenge with or without 5 mM glucose cross_nutrient: true [may2001] Mechanisms of ascorbic acid recycling in human erythrocytes. (2001). https://pubmed.ncbi.nlm.nih.gov/11687303/ DOI: 10.1016/s0304-4165(01)00188-x
Complete structured claim and evidenceDialyzed liver cytosol from selenium-deficient rats lost NADPH-dependent ascorbyl-radical reducing activity attributed to thioredoxin reductase.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- true
- experimental_model
- Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats
- exposure
- Dietary selenium depletion; isolated dialyzed cytosol
- limitations
- Activity assignment also used inhibitor sensitivity; this is a fraction assay, not a direct human outcome.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Rattus norvegicus
- plain_language
- Selenium deficiency impaired radical recycling in the rat liver’s soluble fraction.
- primary_references
- [may1998] Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. (1998). https://pubmed.ncbi.nlm.nih.gov/9722529/ DOI: 10.1074/jbc.273.36.23039
- tissue_or_cell_type
- Liver cytosol
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 429–440
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats · source_derived_draft · unverified_draft
### vc-transport-selenium-cytosolic-radical Dialyzed liver cytosol from selenium-deficient rats lost NADPH-dependent ascorbyl-radical reducing activity attributed to thioredoxin reductase. Condition category: nutrient_deficiency nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Selenium deficiency impaired radical recycling in the rat liver’s soluble fraction. organism: Rattus norvegicus tissue_or_cell_type: Liver cytosol experimental_model: Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats limitations: Activity assignment also used inhibitor sensitivity; this is a fraction assay, not a direct human outcome. exposure: Dietary selenium depletion; isolated dialyzed cytosol cross_nutrient: true [may1998] Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. (1998). https://pubmed.ncbi.nlm.nih.gov/9722529/ DOI: 10.1074/jbc.273.36.23039
Complete structured claim and evidenceAdding 2.8 µM rat liver thioredoxin lowered apparent DHA Km of the thioredoxin-reductase system from 2.5 to 0.7 mM without materially increasing turnover.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver
- exposure
- 2.8 µM thioredoxin added to NADPH/thioredoxin-reductase assay
- limitations
- Apparent kinetic effect is not proof of a faster whole-body recycling rate.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Rattus norvegicus
- plain_language
- Thioredoxin improved the system’s apparent affinity for oxidized vitamin C in this assay.
- primary_references
- [may1997] Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. (1997). https://pubmed.ncbi.nlm.nih.gov/9278416/ DOI: 10.1074/jbc.272.36.22607
- tissue_or_cell_type
- Purified liver enzymes
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 390–401
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver · source_derived_draft · unverified_draft
### vc-transport-thioredoxin-dha-affinity Adding 2.8 µM rat liver thioredoxin lowered apparent DHA Km of the thioredoxin-reductase system from 2.5 to 0.7 mM without materially increasing turnover. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Thioredoxin improved the system’s apparent affinity for oxidized vitamin C in this assay. organism: Rattus norvegicus tissue_or_cell_type: Purified liver enzymes experimental_model: Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver limitations: Apparent kinetic effect is not proof of a faster whole-body recycling rate. exposure: 2.8 µM thioredoxin added to NADPH/thioredoxin-reductase assay cross_nutrient: true [may1997] Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. (1997). https://pubmed.ncbi.nlm.nih.gov/9278416/ DOI: 10.1074/jbc.272.36.22607
Complete structured claim and evidencePurified rat liver thioredoxin reductase reduced DHA using NADPH, with apparent DHA Km 2.5 mM and turnover 90 min−1.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver
- exposure
- Purified enzyme plus NADPH and DHA
- limitations
- Biochemical capacity; not the same as cellular rate at low DHA concentration.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Rattus norvegicus
- plain_language
- Thioredoxin reductase provides another route for recovering reduced vitamin C.
- primary_references
- [may1997] Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. (1997). https://pubmed.ncbi.nlm.nih.gov/9278416/ DOI: 10.1074/jbc.272.36.22607
- tissue_or_cell_type
- Purified liver enzyme
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 377–388
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver · source_derived_draft · unverified_draft
### vc-transport-txnrd-dha Purified rat liver thioredoxin reductase reduced DHA using NADPH, with apparent DHA Km 2.5 mM and turnover 90 min−1. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Thioredoxin reductase provides another route for recovering reduced vitamin C. organism: Rattus norvegicus tissue_or_cell_type: Purified liver enzyme experimental_model: Purified rat liver thioredoxin reductase/thioredoxin and selenium-deficient rat liver limitations: Biochemical capacity; not the same as cellular rate at low DHA concentration. exposure: Purified enzyme plus NADPH and DHA cross_nutrient: true [may1997] Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. (1997). https://pubmed.ncbi.nlm.nih.gov/9278416/ DOI: 10.1074/jbc.272.36.22607
Complete structured claim and evidencePurified rat liver thioredoxin reductase decreased ascorbyl radical measured by electron paramagnetic resonance while consuming NADPH; DHA controls could not explain the signal.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats
- exposure
- Low-micromolar ascorbyl radical generated by ascorbate oxidase
- limitations
- Purified assay; radical and DHA reduction are distinct reactions.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Rattus norvegicus
- plain_language
- The reductase can also recycle the one-electron vitamin C radical.
- primary_references
- [may1998] Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. (1998). https://pubmed.ncbi.nlm.nih.gov/9722529/ DOI: 10.1074/jbc.273.36.23039
- tissue_or_cell_type
- Purified liver enzyme
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 416–427
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats · source_derived_draft · unverified_draft
### vc-transport-txnrd-radical Purified rat liver thioredoxin reductase decreased ascorbyl radical measured by electron paramagnetic resonance while consuming NADPH; DHA controls could not explain the signal. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: The reductase can also recycle the one-electron vitamin C radical. organism: Rattus norvegicus tissue_or_cell_type: Purified liver enzyme experimental_model: Purified rat liver enzyme, dialyzed cytosol and microsomes from control/selenium-deficient rats limitations: Purified assay; radical and DHA reduction are distinct reactions. exposure: Low-micromolar ascorbyl radical generated by ascorbate oxidase cross_nutrient: true [may1998] Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. (1998). https://pubmed.ncbi.nlm.nih.gov/9722529/ DOI: 10.1074/jbc.273.36.23039
Complete structured claim and evidenceRecombinant human CYP26A1 hydroxylated all-trans-retinoic acid to 4-hydroxy-retinoic acid.
Experimental context and source evidence
- cross_nutrient
- NADPH and heme-containing P450 machinery support retinoid oxidation; nutritional deficiency was not tested.
- evidence_location
- Abstract
- experimental_model
- Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays.
- exposure
- All-trans-retinoic-acid concentration series with P450 reductase and NADPH.
- limitations
- Assay kinetics are not whole-body clearance; hydroxylated products are not assumed biologically inert.
- nutrient_topic
- Vitamin A research collection; topical membership is not evidence of a direct dietary effect. · Vitamin A
- organism
- Homo sapiens recombinant protein in insect cells
- outcome
- Recombinant human CYP26A1 hydroxylated all-trans-retinoic acid to 4-hydroxy-retinoic acid.
- plain_language
- This P450 begins oxidative removal of the signaling retinoid.
- primary_references
- [va-topletz-2012] Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases (2012). https://pubmed.ncbi.nlm.nih.gov/22020119/ DOI: 10.1016/j.bcp.2011.10.007
- tissue_or_cell_type
- Reconstituted enzyme/microsomes
Vitamin A: forms, mechanisms, deficiency and excess (2026-09-17) · lines 601–614
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays. · source_derived_draft · unverified_draft
### va-cyp26a1-primary-hydroxylation Recombinant human CYP26A1 hydroxylated all-trans-retinoic acid to 4-hydroxy-retinoic acid. Condition category: normal nutrient_topic: Vitamin A research collection; topical membership is not evidence of a direct dietary effect. plain_language: This P450 begins oxidative removal of the signaling retinoid. organism: Homo sapiens recombinant protein in insect cells tissue_or_cell_type: Reconstituted enzyme/microsomes experimental_model: Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays. limitations: Assay kinetics are not whole-body clearance; hydroxylated products are not assumed biologically inert. exposure: All-trans-retinoic-acid concentration series with P450 reductase and NADPH. outcome: Recombinant human CYP26A1 hydroxylated all-trans-retinoic acid to 4-hydroxy-retinoic acid. evidence_location: Abstract cross_nutrient: NADPH and heme-containing P450 machinery support retinoid oxidation; nutritional deficiency was not tested. [va-topletz-2012] Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases (2012). https://pubmed.ncbi.nlm.nih.gov/22020119/ DOI: 10.1016/j.bcp.2011.10.007
Complete structured claim and evidenceRecombinant human CYP26B1 formed 4-hydroxy-retinoic acid from all-trans-retinoic acid.
Experimental context and source evidence
- evidence_location
- Abstract
- experimental_model
- Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays.
- exposure
- Substrate series with NADPH and P450 reductase.
- limitations
- Lower in vitro turnover than CYP26A1 does not mean lower importance in every tissue.
- nutrient_topic
- Vitamin A research collection; topical membership is not evidence of a direct dietary effect. · Vitamin A
- organism
- Homo sapiens recombinant protein in insect cells
- outcome
- Recombinant human CYP26B1 formed 4-hydroxy-retinoic acid from all-trans-retinoic acid.
- plain_language
- A second independent P450 enzyme also removes the signaling precursor.
- primary_references
- [va-topletz-2012] Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases (2012). https://pubmed.ncbi.nlm.nih.gov/22020119/ DOI: 10.1016/j.bcp.2011.10.007
- tissue_or_cell_type
- Reconstituted enzyme/microsomes
Vitamin A: forms, mechanisms, deficiency and excess (2026-09-17) · lines 616–628
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays. · source_derived_draft · unverified_draft
### va-cyp26b1-primary-hydroxylation Recombinant human CYP26B1 formed 4-hydroxy-retinoic acid from all-trans-retinoic acid. Condition category: normal nutrient_topic: Vitamin A research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second independent P450 enzyme also removes the signaling precursor. organism: Homo sapiens recombinant protein in insect cells tissue_or_cell_type: Reconstituted enzyme/microsomes experimental_model: Human CYP26A1/CYP26B1 expressed in insect cells; purified/reconstituted metabolism and tissue assays. limitations: Lower in vitro turnover than CYP26A1 does not mean lower importance in every tissue. exposure: Substrate series with NADPH and P450 reductase. outcome: Recombinant human CYP26B1 formed 4-hydroxy-retinoic acid from all-trans-retinoic acid. evidence_location: Abstract [va-topletz-2012] Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases (2012). https://pubmed.ncbi.nlm.nih.gov/22020119/ DOI: 10.1016/j.bcp.2011.10.007
Complete structured claim and evidenceRDH10-activated DHRS3 reduced all-trans-retinal to retinol preferentially using NADPH.
Experimental context and source evidence
- cross_nutrient
- NADPH supports a retinoid buffering reaction.
- evidence_location
- Figure 5 and Table 1
- experimental_model
- Human RDH10/DHRS3 coexpression in HEK293 and Sf9 cells, plus Dhrs3-null embryos.
- exposure
- DHRS3 coexpressed with RDH10; retinal plus NADPH.
- limitations
- Cofactor dependency is not a dietary niacin intervention.
- nutrient_topic
- Vitamin A research collection; topical membership is not evidence of a direct dietary effect. · Vitamin A
- organism
- Homo sapiens proteins in Sf9 and HEK293 systems
- outcome
- RDH10-activated DHRS3 reduced all-trans-retinal to retinol preferentially using NADPH.
- plain_language
- This reverse step restrains retinal available for acid production.
- primary_references
- [va-adams-2014] The retinaldehyde reductase activity of DHRS3 is reciprocally activated by retinol dehydrogenase 10 to control retinoid homeostasis (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC4031538/ DOI: 10.1074/jbc.M114.552257
- tissue_or_cell_type
- Microsomal/cellular retinoid system
Vitamin A: forms, mechanisms, deficiency and excess (2026-09-17) · lines 516–529
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human RDH10/DHRS3 coexpression in HEK293 and Sf9 cells, plus Dhrs3-null embryos. · source_derived_draft · unverified_draft
### va-dhrs3-retinal-reduction RDH10-activated DHRS3 reduced all-trans-retinal to retinol preferentially using NADPH. Condition category: normal nutrient_topic: Vitamin A research collection; topical membership is not evidence of a direct dietary effect. plain_language: This reverse step restrains retinal available for acid production. organism: Homo sapiens proteins in Sf9 and HEK293 systems tissue_or_cell_type: Microsomal/cellular retinoid system experimental_model: Human RDH10/DHRS3 coexpression in HEK293 and Sf9 cells, plus Dhrs3-null embryos. limitations: Cofactor dependency is not a dietary niacin intervention. exposure: DHRS3 coexpressed with RDH10; retinal plus NADPH. outcome: RDH10-activated DHRS3 reduced all-trans-retinal to retinol preferentially using NADPH. evidence_location: Figure 5 and Table 1 cross_nutrient: NADPH supports a retinoid buffering reaction. [va-adams-2014] The retinaldehyde reductase activity of DHRS3 is reciprocally activated by retinol dehydrogenase 10 to control retinoid homeostasis (2014). https://pmc.ncbi.nlm.nih.gov/articles/PMC4031538/ DOI: 10.1074/jbc.M114.552257
Complete structured claim and evidenceRecombinant human CYP4F2 catalyzed terminal side-chain hydroxylation of alpha-tocopherol to its 13′-hydroxy product.
Experimental context and source evidence
- cross_nutrient
- false
- experimental_model
- Recombinant human P450 enzyme comparison
- exposure
- alpha-Tocopherol substrate with NADPH; quantitative incubation details not assigned here.
- limitations
- Initial oxidation only; other enzymes perform subsequent side-chain shortening.
- nutrient_topic
- Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
- organism
- Human protein in recombinant microsomes
- plain_language
- CYP4F2 begins breakdown of this tocopherol form.
- primary_references
- [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
- tissue_or_cell_type
- Microsomal enzyme preparation
Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 402–413
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human P450 enzyme comparison · source_derived_draft · unverified_draft
### ve-transport-cyp4f2-alpha-hydroxylation Recombinant human CYP4F2 catalyzed terminal side-chain hydroxylation of alpha-tocopherol to its 13′-hydroxy product. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP4F2 begins breakdown of this tocopherol form. organism: Human protein in recombinant microsomes tissue_or_cell_type: Microsomal enzyme preparation experimental_model: Recombinant human P450 enzyme comparison limitations: Initial oxidation only; other enzymes perform subsequent side-chain shortening. exposure: alpha-Tocopherol substrate with NADPH; quantitative incubation details not assigned here. cross_nutrient: false [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
Complete structured claim and evidenceRecombinant human CYP4F2 catalyzed terminal side-chain hydroxylation of gamma-tocopherol to its 13′-hydroxy product.
Experimental context and source evidence
- cross_nutrient
- false
- experimental_model
- Recombinant human P450 enzyme comparison
- exposure
- gamma-Tocopherol substrate with NADPH; quantitative incubation details not assigned here.
- limitations
- Initial oxidation only; other enzymes perform subsequent side-chain shortening.
- nutrient_topic
- Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
- organism
- Human protein in recombinant microsomes
- plain_language
- CYP4F2 begins breakdown of this tocopherol form.
- primary_references
- [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
- tissue_or_cell_type
- Microsomal enzyme preparation
Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 415–426
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human P450 enzyme comparison · source_derived_draft · unverified_draft
### ve-transport-cyp4f2-gamma-hydroxylation Recombinant human CYP4F2 catalyzed terminal side-chain hydroxylation of gamma-tocopherol to its 13′-hydroxy product. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP4F2 begins breakdown of this tocopherol form. organism: Human protein in recombinant microsomes tissue_or_cell_type: Microsomal enzyme preparation experimental_model: Recombinant human P450 enzyme comparison limitations: Initial oxidation only; other enzymes perform subsequent side-chain shortening. exposure: gamma-Tocopherol substrate with NADPH; quantitative incubation details not assigned here. cross_nutrient: false [sontag2002] Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. (2002). https://pubmed.ncbi.nlm.nih.gov/11997390/ DOI: 10.1074/jbc.m201466200
Complete structured claim and evidenceHuman CYP4F2-expressing microsomes hydroxylated phylloquinone, demonstrating substrate overlap with tocopherol catabolism.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Recombinant CYP4F2 kinetic assay
- exposure
- 25 pmol CYP4F2; labeled phylloquinone 1–100 µM; 1 mM NADPH; 30 min at 37 °C.
- limitations
- Shared substrate use alone does not imply vitamin E accelerates vitamin K depletion.
- nutrient_topic
- Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
- organism
- Human protein in insect microsomes
- plain_language
- Vitamins E and K1 share an initial catabolic enzyme.
- primary_references
- [farley2013] ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol. (2013). https://pubmed.ncbi.nlm.nih.gov/23650179/ DOI: 10.1002/mnfr.201200797
- tissue_or_cell_type
- Microsomal enzyme preparation
Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 454–465
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant CYP4F2 kinetic assay · source_derived_draft · unverified_draft
### ve-transport-cyp4f2-k1-hydroxylation Human CYP4F2-expressing microsomes hydroxylated phylloquinone, demonstrating substrate overlap with tocopherol catabolism. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamins E and K1 share an initial catabolic enzyme. organism: Human protein in insect microsomes tissue_or_cell_type: Microsomal enzyme preparation experimental_model: Recombinant CYP4F2 kinetic assay limitations: Shared substrate use alone does not imply vitamin E accelerates vitamin K depletion. exposure: 25 pmol CYP4F2; labeled phylloquinone 1–100 µM; 1 mM NADPH; 30 min at 37 °C. cross_nutrient: true [farley2013] ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol. (2013). https://pubmed.ncbi.nlm.nih.gov/23650179/ DOI: 10.1002/mnfr.201200797
Complete structured claim and evidenceThe rat cytosolic epimerase assay required NADH and NADPH for full activity.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/inositol-research/12051772.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154", "start_char": 0, "end_char": 2218, "text_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154"}
- experimental_model
- Radiotracer conversion and cytosolic enzyme assays
- exposure
- Diabetic rat versus controls; reduced pyridine-nucleotide cofactors
- limitations
- The molecular identity of the activity was not established here. A later mouse stable-isotope study found no myo-to-D-chiro conversion; the research disagreement is recorded separately. Do not invent a human epimerase gene or infer a universal supplement ratio.
- nutrient_topic
- Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
- organism
- Goto-Kakizaki and Wistar rats
- plain_language
- Reduced niacin-derived cofactors supported the observed conversion.
- primary_references
- [ino-p12051772] Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. (2002). https://pubmed.ncbi.nlm.nih.gov/12051772/ DOI: 10.1016/s0006-291x(02)00313-3
- tissue_or_cell_type
- Liver, muscle, kidney and adipose preparations
Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1185–1196
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiotracer conversion and cytosolic enzyme assays · source_derived_draft · unverified_draft
### ino-epimerase-nadh The rat cytosolic epimerase assay required NADH and NADPH for full activity. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Reduced niacin-derived cofactors supported the observed conversion. organism: Goto-Kakizaki and Wistar rats tissue_or_cell_type: Liver, muscle, kidney and adipose preparations experimental_model: Radiotracer conversion and cytosolic enzyme assays limitations: The molecular identity of the activity was not established here. A later mouse stable-isotope study found no myo-to-D-chiro conversion; the research disagreement is recorded separately. Do not invent a human epimerase gene or infer a universal supplement ratio. exposure: Diabetic rat versus controls; reduced pyridine-nucleotide cofactors evidence_span: {"source_cache": "artifacts/inositol-research/12051772.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154", "start_char": 0, "end_char": 2218, "text_sha256": "28ae1225b489898738997d2376ab09857f017314086979032d3ad907299a1154"} [ino-p12051772] Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. (2002). https://pubmed.ncbi.nlm.nih.gov/12051772/ DOI: 10.1016/s0006-291x(02)00313-3
Complete structured claim and evidencePhosphopantetheinylation restored recombinant ALDH1L2 folate dehydrogenase activity with NADPH formation.
Experimental context and source evidence
- cross_nutrient
- CoA maturation enables the folate-to-NADPH reaction.
- experimental_model
- Recombinant enzyme activation assay
- exposure
- Assay conditions described in the linked primary study.
- limitations
- Figure 5 used stable dideazafolate analogue rather than physiological folate.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- The installed arm enables oxidation of folate-bound carbon.
- primary_references
- [strickland-2011] Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase (2011). https://pubmed.ncbi.nlm.nih.gov/21238436/ DOI: 10.1016/j.cbi.2011.01.008
- tissue_or_cell_type
- Cell-free
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1059–1070
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant enzyme activation assay · source_derived_draft · unverified_draft
### aldh1l2-activation-folate-oxidation Phosphopantetheinylation restored recombinant ALDH1L2 folate dehydrogenase activity with NADPH formation. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The installed arm enables oxidation of folate-bound carbon. organism: Homo sapiens tissue_or_cell_type: Cell-free experimental_model: Recombinant enzyme activation assay limitations: Figure 5 used stable dideazafolate analogue rather than physiological folate. exposure: Assay conditions described in the linked primary study. cross_nutrient: CoA maturation enables the folate-to-NADPH reaction. [strickland-2011] Enzymatic properties of ALDH1L2, a mitochondrial 10-formyltetrahydrofolate dehydrogenase (2011). https://pubmed.ncbi.nlm.nih.gov/21238436/ DOI: 10.1016/j.cbi.2011.01.008
Complete structured claim and evidenceHuman liver DHFR converted 7,8-dihydrofolate to tetrahydrofolate in NADPH-containing assays.
Experimental context and source evidence
- experimental_model
- Fresh human liver extracts from six donors and rat comparison
- exposure
- DHF substrate; THF quantified by HPLC
- limitations
- Assay chemistry, not an outcome study.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- DHFR regenerates reduced folate from DHF.
- primary_references
- [bailey2009] The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake (2009). https://pubmed.ncbi.nlm.nih.gov/19706381/ DOI: 10.1073/pnas.0902072106
- tissue_or_cell_type
- Liver extracts
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 363–373
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Fresh human liver extracts from six donors and rat comparison · source_derived_draft · unverified_draft
### folate-dhfr-dhf-recycling Human liver DHFR converted 7,8-dihydrofolate to tetrahydrofolate in NADPH-containing assays. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: DHFR regenerates reduced folate from DHF. organism: Homo sapiens tissue_or_cell_type: Liver extracts experimental_model: Fresh human liver extracts from six donors and rat comparison limitations: Assay chemistry, not an outcome study. exposure: DHF substrate; THF quantified by HPLC [bailey2009] The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake (2009). https://pubmed.ncbi.nlm.nih.gov/19706381/ DOI: 10.1073/pnas.0902072106
Complete structured claim and evidenceDHFR reduces folic acid to dihydrofolate before further reduction to tetrahydrofolate.
Experimental context and source evidence
- experimental_model
- Fresh human liver extracts from six donors and rat comparison
- exposure
- Folic acid substrate with NADPH
- limitations
- Reaction identity; liver rates cannot define a universal intake ceiling.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Folic acid needs a reduction step before it becomes usable folate.
- primary_references
- [bailey2009] The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake (2009). https://pubmed.ncbi.nlm.nih.gov/19706381/ DOI: 10.1073/pnas.0902072106
- tissue_or_cell_type
- Liver enzyme preparations
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 351–361
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Fresh human liver extracts from six donors and rat comparison · source_derived_draft · unverified_draft
### folate-dhfr-folic-acid-first-reduction DHFR reduces folic acid to dihydrofolate before further reduction to tetrahydrofolate. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Folic acid needs a reduction step before it becomes usable folate. organism: Homo sapiens tissue_or_cell_type: Liver enzyme preparations experimental_model: Fresh human liver extracts from six donors and rat comparison limitations: Reaction identity; liver rates cannot define a universal intake ceiling. exposure: Folic acid substrate with NADPH [bailey2009] The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake (2009). https://pubmed.ncbi.nlm.nih.gov/19706381/ DOI: 10.1073/pnas.0902072106
Complete structured claim and evidenceHuman MTRR stabilized apo-MTR and enhanced holoenzyme formation from methylcobalamin in the presence of NADPH.
Experimental context and source evidence
- cross_nutrient
- Flavin-dependent MTRR supports B12-enzyme assembly.
- experimental_model
- Human MTR/MTRR expressed in insect cells; purified enzymes and extracts.
- limitations
- In-vitro assembly.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- MTRR also helps MTR acquire its cofactor.
- primary_references
- [yamada-2006] Human methionine synthase reductase is a molecular chaperone for human methionine synthase (2006). https://pubmed.ncbi.nlm.nih.gov/16769880/ DOI: 10.1073/pnas.0603694103
- tissue_or_cell_type
- Human proteins expressed in insect cells
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 494–504
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human MTR/MTRR expressed in insect cells; purified enzymes and extracts. · source_derived_draft · unverified_draft
### folate-methyl-mtrr-apoenzyme Human MTRR stabilized apo-MTR and enhanced holoenzyme formation from methylcobalamin in the presence of NADPH. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: MTRR also helps MTR acquire its cofactor. organism: Homo sapiens tissue_or_cell_type: Human proteins expressed in insect cells experimental_model: Human MTR/MTRR expressed in insect cells; purified enzymes and extracts. limitations: In-vitro assembly. cross_nutrient: Flavin-dependent MTRR supports B12-enzyme assembly. [yamada-2006] Human methionine synthase reductase is a molecular chaperone for human methionine synthase (2006). https://pubmed.ncbi.nlm.nih.gov/16769880/ DOI: 10.1073/pnas.0603694103
Complete structured claim and evidenceNuclear MTHFD1 supplies formate-derived one-carbon units for thymidylate synthesis through its folate-interconversion activities.
Experimental context and source evidence
- cross_nutrient
- ATP and NADPH support folate-mediated carbon use.
- experimental_model
- Localization and folate-pathway experiments
- exposure
- Assay conditions described in the linked primary study.
- limitations
- Compartmental flux varies with cell cycle.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Formate can feed DNA-base production inside the nucleus.
- primary_references
- [field-2014] Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency (2014). https://pubmed.ncbi.nlm.nih.gov/25213861/ DOI: 10.1074/jbc.m114.599589
- tissue_or_cell_type
- HeLa and MCF7 cells
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 936–947
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Localization and folate-pathway experiments · source_derived_draft · unverified_draft
### mthfd1-formate-nuclear-carbon Nuclear MTHFD1 supplies formate-derived one-carbon units for thymidylate synthesis through its folate-interconversion activities. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Formate can feed DNA-base production inside the nucleus. organism: Homo sapiens tissue_or_cell_type: HeLa and MCF7 cells experimental_model: Localization and folate-pathway experiments limitations: Compartmental flux varies with cell cycle. exposure: Assay conditions described in the linked primary study. cross_nutrient: ATP and NADPH support folate-mediated carbon use. [field-2014] Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency (2014). https://pubmed.ncbi.nlm.nih.gov/25213861/ DOI: 10.1074/jbc.m114.599589
Complete structured claim and evidenceHuman MTHFD2 also uses NADP+ with methylene-THF pentaglutamate; NADP-linked activity increases relative to the monoglutamate assay.
Experimental context and source evidence
- cross_nutrient
- Folate polyglutamylation changes nicotinamide-cofactor use.
- experimental_model
- Purified recombinant enzyme
- exposure
- Mono- versus pentaglutamate folate substrates; controlled NAD(P)+ assays.
- limitations
- Kinetics do not establish dominant in vivo NADPH production.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- The folate tail affects which electron carrier the enzyme uses.
- primary_references
- [shin-2017] Human mitochondrial MTHFD2 is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase (2017). https://pubmed.ncbi.nlm.nih.gov/29225823/ DOI: 10.1186/s40170-017-0173-0
- tissue_or_cell_type
- Cell-free
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 825–836
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant enzyme · source_derived_draft · unverified_draft
### mthfd2-nadp-polyglutamate Human MTHFD2 also uses NADP+ with methylene-THF pentaglutamate; NADP-linked activity increases relative to the monoglutamate assay. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The folate tail affects which electron carrier the enzyme uses. organism: Homo sapiens tissue_or_cell_type: Cell-free experimental_model: Purified recombinant enzyme limitations: Kinetics do not establish dominant in vivo NADPH production. exposure: Mono- versus pentaglutamate folate substrates; controlled NAD(P)+ assays. cross_nutrient: Folate polyglutamylation changes nicotinamide-cofactor use. [shin-2017] Human mitochondrial MTHFD2 is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase (2017). https://pubmed.ncbi.nlm.nih.gov/29225823/ DOI: 10.1186/s40170-017-0173-0
Complete structured claim and evidenceK476E reduced NADPH oxidation and ferric-enzyme reduction; excess reductase did not restore wild-type coumarin hydroxylation.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/coumarin-research/16207711.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7", "start_char": 0, "end_char": 1740, "text_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7"}
- experimental_model
- Random mutagenesis of recombinant human CYP2A6
- exposure
- Wild-type enzyme and selected activity-reducing mutants
- limitations
- Engineered protein dysfunction is not nutrient deficiency; no rescue by nutritional supplementation was tested.
- nutrient_topic
- Coumarin research collection; topical membership is not evidence of a direct dietary effect. · Coumarin
- organism
- Human engineered protein
- plain_language
- Adding more partner enzyme did not fully repair this variant.
- primary_references
- [coumarin-p16207711] Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. (2005). https://pubmed.ncbi.nlm.nih.gov/16207711/ DOI: 10.1074/jbc.m508171200
- tissue_or_cell_type
- Reconstituted enzyme system
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Coumarin: metabolism, signaling and nutrient connections (2026-09-17) · lines 618–629
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Random mutagenesis of recombinant human CYP2A6 · source_derived_draft · unverified_draft
### coumarin-k476e-hydroxylation K476E reduced NADPH oxidation and ferric-enzyme reduction; excess reductase did not restore wild-type coumarin hydroxylation. Condition category: machinery_impairment nutrient_topic: Coumarin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding more partner enzyme did not fully repair this variant. organism: Human engineered protein tissue_or_cell_type: Reconstituted enzyme system experimental_model: Random mutagenesis of recombinant human CYP2A6 limitations: Engineered protein dysfunction is not nutrient deficiency; no rescue by nutritional supplementation was tested. exposure: Wild-type enzyme and selected activity-reducing mutants evidence_span: {"source_cache": "artifacts/coumarin-research/16207711.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7", "start_char": 0, "end_char": 1740, "text_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7"} [coumarin-p16207711] Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. (2005). https://pubmed.ncbi.nlm.nih.gov/16207711/ DOI: 10.1074/jbc.m508171200
Complete structured claim and evidenceCYP2A6 K476E had lower affinity for NADPH-P450 reductase, contributing to reduced catalytic activity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/coumarin-research/16207711.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7", "start_char": 0, "end_char": 1740, "text_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7"}
- experimental_model
- Random mutagenesis of recombinant human CYP2A6
- exposure
- Wild-type enzyme and selected activity-reducing mutants
- limitations
- Engineered protein dysfunction is not nutrient deficiency; no rescue by nutritional supplementation was tested.
- nutrient_topic
- Coumarin research collection; topical membership is not evidence of a direct dietary effect. · Coumarin
- organism
- Human engineered protein
- plain_language
- A protein change weakened its connection to the electron donor.
- primary_references
- [coumarin-p16207711] Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. (2005). https://pubmed.ncbi.nlm.nih.gov/16207711/ DOI: 10.1074/jbc.m508171200
- tissue_or_cell_type
- Reconstituted enzyme system
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Coumarin: metabolism, signaling and nutrient connections (2026-09-17) · lines 605–616
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Random mutagenesis of recombinant human CYP2A6 · source_derived_draft · unverified_draft
### coumarin-k476e-por CYP2A6 K476E had lower affinity for NADPH-P450 reductase, contributing to reduced catalytic activity. Condition category: machinery_impairment nutrient_topic: Coumarin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A protein change weakened its connection to the electron donor. organism: Human engineered protein tissue_or_cell_type: Reconstituted enzyme system experimental_model: Random mutagenesis of recombinant human CYP2A6 limitations: Engineered protein dysfunction is not nutrient deficiency; no rescue by nutritional supplementation was tested. exposure: Wild-type enzyme and selected activity-reducing mutants evidence_span: {"source_cache": "artifacts/coumarin-research/16207711.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7", "start_char": 0, "end_char": 1740, "text_sha256": "a5f0bef9ac62d55ff5725e8c5cb4eca3e76ef715c758654e76c0c596c52ceab7"} [coumarin-p16207711] Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. (2005). https://pubmed.ncbi.nlm.nih.gov/16207711/ DOI: 10.1074/jbc.m508171200
Complete structured claim and evidenceThe second oxygenation yielded NO and citrulline and required added NADPH and calcium/calmodulin.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat cerebellar NOS preparation; separated partial reactions.
- limitations
- Purified preparation; residual enzyme reductant supported a limited first reaction without added NADPH. This does not imply physiological NOS is NADPH independent.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- The next reaction produces the signal and recycles the carbon skeleton.
- primary_references
- Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 78–84
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat cerebellar NOS preparation; separated partial reactions. · source_derived_draft · unverified_draft
## arg-nos-second The next reaction produces the signal and recycles the carbon skeleton. The second oxygenation yielded NO and citrulline and required added NADPH and calcium/calmodulin. Model: Rat cerebellar NOS preparation; separated partial reactions. Limitations: Purified preparation; residual enzyme reductant supported a limited first reaction without added NADPH. This does not imply physiological NOS is NADPH independent. Evidence access: Primary abstract Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
Complete structured claim and evidenceNADPH-fortified rat hepatic microsomes converted 6-gingerol into a mixture of tentatively identified metabolites.
Experimental context and source evidence
- dose
- 6-Gingerol with NADPH; exact concentrations not in accessed abstract
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Rat hepatic microsomes
- limitations
- Metabolite assignments were tentative; neither a specific human CYP nor dietary NADPH depletion is established.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Rat hepatic microsomes
- plain_language
- NADPH-fortified rat hepatic microsomes converted 6-gingerol into a mixture of tentatively identified metabolites.
- primary_references
- Microsomal hydroxylation and glucuronidation of [6]-gingerol. (2006). https://pubmed.ncbi.nlm.nih.gov/17090120/ DOI: 10.1021/jf062235l
- route
- In vitro microsomal incubation
- tissue
- Liver microsomal preparation
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 261–270
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Rat hepatic microsomes · source_derived_draft · unverified_draft
## gingerols-6-rat-metabolism NADPH-fortified rat hepatic microsomes converted 6-gingerol into a mixture of tentatively identified metabolites. Model/species: Rat hepatic microsomes Tissue: Liver microsomal preparation Exposure: 6-Gingerol with NADPH; exact concentrations not in accessed abstract Route: In vitro microsomal incubation Duration: Not specified in accessed abstract Limits: Metabolite assignments were tentative; neither a specific human CYP nor dietary NADPH depletion is established. Primary reference: Microsomal hydroxylation and glucuronidation of [6]-gingerol. (2006). https://pubmed.ncbi.nlm.nih.gov/17090120/ DOI: 10.1021/jf062235l Access: Primary PubMed abstract.
Complete structured claim and evidenceCytosolic TXNRD1 uses NADPH-derived reducing equivalents to reduce oxidized thioredoxin through its flavin and C-terminal redox centers.
Experimental context and source evidence
- experimental_model
- Purified rat liver cytosolic thioredoxin reductase and recombinant active-site variants.
- limitations
- This experiment-specific relationship does not establish a human dietary-deficiency threshold or supplementation benefit.
- organism
- Rat protein and recombinant enzyme assays
Selenium: literature corrections and mechanism additions · lines 965–974
Metabolic Ledger literature curation, 17 September 2026; primary papers linked individually · supports · Purified rat liver cytosolic thioredoxin reductase and recombinant active-site variants. · secondary_verified · secondary_verified
## txnrd1-reduces-txn1 TXNRD1 recharges thioredoxin so it can reduce other proteins. Cytosolic TXNRD1 uses NADPH-derived reducing equivalents to reduce oxidized thioredoxin through its flavin and C-terminal redox centers. Experimental model: Purified rat liver cytosolic thioredoxin reductase and recombinant active-site variants. Organism: Rat protein and recombinant enzyme assays Limitations: This experiment-specific relationship does not establish a human dietary-deficiency threshold or supplementation benefit. Primary reference: [Mammalian thioredoxin reductase: C-terminal redox center and selenium-to-sulfur substitution](https://pmc.ncbi.nlm.nih.gov/articles/PMC15961/)
Complete structured claim and evidenceTXNRD2 uses NADPH-derived reducing equivalents to regenerate reduced TXN2.
Experimental context and source evidence
- cell_type
- cardiac mitochondria
- experimental_model
- Redox perturbation and peroxide-emission assays
- limitations
- Functional relay; not every chemical step isolated here.
- organism
- mouse and guinea pig
Selenium: literature corrections and mechanism additions · lines 606–616
Metabolic Ledger literature curation, 17 September 2026; primary papers linked individually · supports · Redox perturbation and peroxide-emission assays · secondary_verified · secondary_verified
## txnrd2-reduces-txn2 A selenium enzyme restores mitochondrial thioredoxin's reducing power. TXNRD2 uses NADPH-derived reducing equivalents to regenerate reduced TXN2. Organism: mouse and guinea pig Cell type: cardiac mitochondria Experimental model: Redox perturbation and peroxide-emission assays Limitations: Functional relay; not every chemical step isolated here. Primary reference: [Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria](https://pubmed.ncbi.nlm.nih.gov/21832082/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.